FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Fonseca, BD
   Albuquerque, PC
   Zicker, F
AF Fonseca, Bruna de Paula
   Albuquerque, Priscila Costa
   Zicker, Fabio
TI Neglected tropical diseases in Brazil: lack of correlation between
   disease burden, research funding and output
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article; Early Access
DE disease burden; funding; neglected tropical diseases; Brazil
ID HEALTH
AB Objectives To assess the correlation between the burden of seven priority neglected tropical diseases (NTDs) included in the Brazilian National Agenda of Priorities in Health Research - tuberculosis, Chagas disease, leprosy, malaria, leishmaniasis, dengue and schistosomiasis - and their respective research funding and output. Methods This retrospective review obtained data on disease burden from the Global Burden of Disease Study and funding data from open access sources. Publications were retrieved from Scopus and SciELO, and characterised according to the type of research conducted. Correlation between funding, research output and burden was assessed by comparing the 'expected' and 'observed' values for funding and publications relative to the proportional burden for each disease. Results There was an emphasis in basic biomedical research (average 30% of publications) and a shortage of health policy and systems (average 7%) and social sciences research (average 3%). Research output and funding were poorly correlated with disease burden. Tuberculosis, Chagas disease and schistosomiasis accounted for more than 75% of total NTD-related DALYs, but accounted for only 34% of publications. Leprosy, leishmaniasis and malaria, together, received 49% of NTD-related funding despite being responsible for only 9% of DALYs. Conclusions The analysis evidenced a lack of correlation between disease burden, research output and government funding for priority NTDs in Brazil. Our findings highlight the importance of monitoring health needs, research investments and outputs to inform policy and optimise the uptake of evidence for action, particularly in developing countries, where resources are scarce and the research capacity is limited. The results contribute to health policy by highlighting the need for improving coordination of scientific activities and public health needs for effective impact.
C1 [Fonseca, Bruna de Paula; Albuquerque, Priscila Costa; Zicker, Fabio] Fundacao Oswaldo Cruz, Ctr Technol Dev Hlth, Manguinho, RJ, Brazil.
RP Fonseca, BD (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Av Brasil 4036, Manguinho, RJ, Brazil.
EM brufonseca@gmail.com
FU Fundacao Oswaldo Cruz (Fiocruz); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq) [407060/2018-9]; Instituto Nacional de
   Ciencia e Tecnologia de Inovacao em Doencas de Populacoes Negligenciadas
   (INCT-IDPN); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES) pos doctoral fellowshipCAPES [001]
FX This work was supported by Fundacao Oswaldo Cruz (Fiocruz), Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [grant
   #407060/2018-9], Instituto Nacional de Ciencia e Tecnologia de Inovacao
   em Doencas de Populacoes Negligenciadas (INCT-IDPN) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) pos doctoral
   fellowship Finance Code 001. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Albarqouni L, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0302-4
   Allotey P, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-32
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   de Oliveira RG, 2018, CIENC SAUDE COLETIVA, V23, P2291, DOI 10.1590/1413-81232018237.09042018
   Evans JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090147
   Glanzel W, 2006, SCIENTOMETRICS, V67, P67, DOI 10.1556/Scient.67.2006.1.5
   Global Burden of Disease Collaborative Network, 2018, GLOB BURD DIS STUD 2
   Gonzalez Block Miguel A, 2003, Health Res Policy Syst, V1, P1, DOI 10.1186/1478-4505-1-1
   Gonzalez-Block Miguel A, 2004, Health Res Policy Syst, V2, P6, DOI 10.1186/1478-4505-2-6
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005309
   Hotez PJ, 2014, MICROBES INFECT, V16, P601, DOI 10.1016/j.micinf.2014.07.006
   Iltis AS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005431
   Kappagoda S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6512
   Kinge JM, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-64
   Kleinman MS, 2009, CTS-CLIN TRANSL SCI, V2, P312, DOI 10.1111/j.1752-8062.2009.00119.x
   Kritski A, 2016, I HIG MED TROP, V15, pS35
   Lienhardt C, 2014, NATURE, V507, P401, DOI 10.1038/507401a
   McGregor S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108787
   Medecins Sans Frontieres, 2001, ACCESS ESSENTIAL MED
   Minist Saude, 2010, REV SAUDE PUBL, V44, P200
   Ministry of Health, 2006, NAT AG PRIOR HLTH RE
   Moran M, 2009, PLOS MED, V6, P137, DOI 10.1371/journal.pmed.1000030
   Nahin RL, 2005, FASEB J, V19, P1209, DOI 10.1096/fj.05-3727LFE
   Perel P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001696
   PLOS Neglected Tropical Diseases, 2020, PLOS NEGLECTED TROPI
   Rees CA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007111
   Santos SS, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105906
   Sridhar D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001312
   Stilgoe J, 2013, RES POLICY, V42, P1568, DOI 10.1016/j.respol.2013.05.008
   Stockmann C, 2014, INT J CARDIOL, V172, pE16, DOI 10.1016/j.ijcard.2013.12.095
   Terry RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-25
   Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0
   Uniting to combat neglected tropical diseases, 2012, LONDON DECLARATION N
   Vasconcellos AG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006469
   Vermelho AB, 2020, EXPERT OPIN DRUG DIS, V15, P145, DOI 10.1080/17460441.2020.1681394
   Ward D, 2013, J HEALTH SERV RES PO, V18, P7, DOI 10.1177/1355819613476015
   Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237
   WHO, 2020, END NEGL ATT SUST DE
   WHO, 2018, METR DIS ADJ LIF YEA
   WHO, 2001, MACROECONOMICS HLTH
   World heart organization, 2020, NEGLECTED TROPICAL D
NR 41
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
DI 10.1111/tmi.13478
EA SEP 2020
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA NP0FK
UT WOS:000569859400001
PM 32860446
DA 2020-11-10
ER

PT J
AU Machado-Silva, A
   Guindalini, C
   Fonseca, FL
   Pereira-Silva, MV
   Fonseca, BD
AF Machado-Silva, Alice
   Guindalini, Camila
   Fonseca, Fernanda Lopes
   Pereira-Silva, Marcus Vinicius
   Fonseca, Bruna de Paula
TI Scientific and technological contributions of Latin America and
   Caribbean countries to the Zika virus outbreak
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Zika; Latin America; S&T; Epidemic; Patents; Publications; Co-authorship
   networks
ID SCIENTOMETRIC ANALYSIS; BIBLIOMETRIC ANALYSIS; PUBLICATIONS; NETWORKS;
   SCIELO
AB BackgroundThe recent Zika virus (ZIKAV) epidemics disclosed a major public health threat and a scientific and technological (S&T) challenge. The lessons learned from the S&T response of Latin America and the Caribbean (LAC) countries are critical to inform further research and guide scientific investments. The present study aimed to assess how new S&T knowledge produced and disseminated regionally can contribute to address global health challenges.MethodsScientometric and social network analysis methods were used to assess the LAC scientific contribution and potential technological development on ZIKAV up to December 2017. ZIKAV-related publications were retrieved from the Web of Science, Scopus, and PubMed databases. Regionally published articles were obtained from SciELO (Scientific Electronic Library Online) and LILACS (Literature in the Health Sciences in Latin America and the Caribbean) databases. Patent registries were retrieved using Orbit Intelligence and Derwent Innovation. Records from each database were individually downloaded, integrated, standardized and analyzed.ResultsWe retrieved 5421 ZIKAV-related publications, revealing a sharp increase from 2015 onwards. LAC countries accounted for 20% of all publications and Brazil was among the top three most central countries in the global network for ZIKAV research. A total of 274 patent families backed up by experimental evidence were retrieved. Only 5% were filed by LAC assignees, all of them based in Brazil. The largest contribution of LAC research was on the clinical manifestations of the ZIKAV infection, along with vector control, which was also the main focusof patents.ConclusionsOur analysis offered a comprehensive overview of ZIKAV's research and development and showed that (i) LAC countries had a key role in generating and disseminating scientific knowledge on ZIKAV; (ii) LAC countries have expressively contributed to research on ZIKAV clinical manifestations; (iii) the Brazilian scientific community was potentially very effective in knowledge sharing and diffusion in the ZIKAV research network; (iv) Brazil was the single LAC country filing patents, mostly represented by independent inventors and low-tech patents. The paper advocates the need for a continued interdisciplinary approach to improve LAC countries ability to prevent, prepare for and control future outbreaks.
C1 [Machado-Silva, Alice; Guindalini, Camila; Fonseca, Fernanda Lopes; Fonseca, Bruna de Paula] Fiocruz MS, CDTS, Rio De Janeiro, Brazil.
   [Pereira-Silva, Marcus Vinicius] Fiocruz MS, Casa Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Machado-Silva, Alice] Fiocruz MS, Inst Rene Rachou, Belo Horizonte, MG, Brazil.
   [Guindalini, Camila; Fonseca, Fernanda Lopes; Pereira-Silva, Marcus Vinicius; Fonseca, Bruna de Paula] Fiocruz MS, Observ Ciencia Tecnol & Inovacao Saude, Rio De Janeiro, Brazil.
RP Fonseca, BD (corresponding author), Fiocruz MS, CDTS, Rio De Janeiro, Brazil.; Fonseca, BD (corresponding author), Fiocruz MS, Observ Ciencia Tecnol & Inovacao Saude, Rio De Janeiro, Brazil.
EM brufonseca@gmail.com
RI Fonseca, Fernanda/V-3446-2019; Pereira-Silva, Marcus
   Vinicius/AAD-8584-2020
OI Pereira-Silva, Marcus Vinicius/0000-0002-4135-4011; Guindalini,
   Camila/0000-0002-6278-5881; Fonseca, Bruna de Paula/0000-0002-8795-2578
FU Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas
   Negligenciadas (INCT-IDN)
FX Fundacao Oswaldo Cruz provided support in the form of salaries for
   authors AMS, CG, FLF and BPF. Software licenses were funded by the
   Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas
   Negligenciadas (INCT-IDN). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Albuquerque PC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005132
   Attaran A, 2016, PODIUM WHY PUBLIC HL
   Bastian M., 2009, 3 INT AAAI C WEBL SO
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC, 2014, ZIK VIR
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Delwiche Frances A., 2018, Science & Technology Libraries, V37, P113, DOI 10.1080/0194262X.2018.1431589
   Depoux A, 2018, PUBLIC HLTH REV, V39
   Diamond MS, 2017, NAT REV IMMUNOL
   Dye C, 2016, B WORLD HEALTH ORGAN, V94, P158, DOI 10.2471/BLT.16.170860
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Erbelding E, 2017, J INFECT DIS, V216, pS991, DOI 10.1093/infdis/jix492
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3
   Ventura DDL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00033316
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meneghini R, 2006, SCIENTOMETRICS, V69, P529, DOI 10.1007/s11192-006-0168-z
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Morel CM, 2005, HLTH INNOVATION DEV
   OECD, 2009, OECD PAT STAT MAN
   Singh Nirmal, 2016, VirusDisease, V27, P303, DOI 10.1007/s13337-016-0339-3
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   van Eck NJ, 2009, J AM SOC INF SCI TEC, V60, P1635, DOI 10.1002/asi.21075
   Vasconcellos AG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006469
   Velez-Cuartas G, 2016, PROF INFORM, V25, P35, DOI 10.3145/epi.2016.ene.05
   Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002
   WHO, 2017, ZIK RESP FUND
   WHO, 2016, WHO DIR GEN SUMM OUT
   WHO, WHO ZIK R D
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 37
TC 2
Z9 2
U1 1
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 9
PY 2019
VL 19
AR 530
DI 10.1186/s12889-019-6842-x
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HX7TR
UT WOS:000467609400002
PM 31072386
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT S
AU Pereira-Silva, MV
   Fonseca, FL
   Fonseca, BD
   Guindalini, C
   Ferrari, R
   dos Santos, PX
AF Pereira-Silva, Marcus Vinicius
   Fonseca, Fernanda Lopes
   Fonseca, Bruna de Paula
   Guindalini, Camila
   Ferrari, Rodrigo
   dos Santos, Paula Xavier
BE Catalano, G
   Daraio, C
   Gregori, M
   Moed, HF
   Ruocco, G
TI Science, technology and innovation indicators to support research
   management: the case of Oswaldo Cruz Foundation (Fiocruz)
SO 17TH INTERNATIONAL CONFERENCE ON SCIENTOMETRICS & INFORMETRICS
   (ISSI2019), VOL II
SE Proceedings of the International Conference on Scientometrics and
   Informetrics
LA English
DT Proceedings Paper
CT 17th International Conference of the
   International-Society-for-Scientometrics-and-Informetrics (ISSI) on
   Scientometrics and Informetrics
CY SEP 02-05, 2019
CL Sapienza Univ Rome, Rome, ITALY
SP Int Soc Scientometr & Informetr
HO Sapienza Univ Rome
C1 [Pereira-Silva, Marcus Vinicius; Fonseca, Fernanda Lopes; Fonseca, Bruna de Paula; Guindalini, Camila; Ferrari, Rodrigo; dos Santos, Paula Xavier] Fundacao Oswaldo Cruz, Av Brasil 4365,Sala 7, BR-21040900 Rio De Janeiro, Brazil.
RP Pereira-Silva, MV (corresponding author), Fundacao Oswaldo Cruz, Av Brasil 4365,Sala 7, BR-21040900 Rio De Janeiro, Brazil.
EM marcus.silva@fiocruz.br; ffonseca@.cdts.fiocruz.br;
   bfonseca@cdts.fiocruz.br; cguindalini@cdts.fiocruz.br;
   rodrigo.ferrari@fiocruz.br; paula.xavier@fiocruz.br
CR Ferreira JR, 2016, HIST CIENC SAUDE-MAN, V23, DOI 10.1590/S0104-59702016000200002
   Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a
   United Nations, 2019, WORLD EC SIT PROSP 2
NR 3
TC 0
Z9 0
U1 0
U2 0
PU INT SOC SCIENTOMETRICS & INFORMETRICS-ISSI
PI LEUVEN
PA KATHOLIEKE UNIV LEUVEN, FACULTEIT E T E W, DEKENSTRAAT 2, LEUVEN,
   B-3000, BELGIUM
SN 2175-1935
BN 978-88-3381-118-5
J9 PRO INT CONF SCI INF
PY 2019
BP 2680
EP 2681
PG 2
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA BO2SO
UT WOS:000508227200226
DA 2020-11-10
ER

PT J
AU Albuquerque, PC
   Fonseca, BDFE
   Girard-Dias, W
   Zicker, F
   de Souza, W
   Miranda, K
AF Albuquerque, Priscila C.
   Fonseca e Fonseca, Bruna de Paula
   Girard-Dias, Wendell
   Zicker, Fabio
   de Souza, Wanderley
   Miranda, Kildare
TI Mapping the Brazilian microscopy landscape: A bibliometric and network
   analysis
SO MICRON
LA English
DT Article
DE Microscopy survey Brazil; Brazilian microscopy landscape; Network
   analysis
ID SCIENCE
AB Understanding how a technology is introduced and shared in a society has a strategic value for the planning of technological development and assessing new market opportunities. Among other technologies, microscopy has had a significant role in advancing different fields of science. In Brazil, its use spans from biomedical to engineering areas. Here, we used social network analysis (SNA) to map and quantify the flow of interaction between Brazilian researchers involved in microscopy techniques. The analysis examines co-occurrence of thematic networks and scientific co-authorship in articles published in a ten years window, as retrieved from Scopus database. The results showed an increasing volume of publications using microscopy in Brazil. The two major areas of interest are material and life sciences, which present significant intra-regional interaction. USA, Spain, Germany, Portugal and the United Kingdom are the main partner countries for international scientific collaborations. The share of Brazilian publications applying microscopy follows the global trends, with a slight predominance in health and life sciences. Our results provide a context of the strengths and gaps of the field in Brazil and may help to inform researchers and policy makers for further advancing the field.
C1 [Albuquerque, Priscila C.; Fonseca e Fonseca, Bruna de Paula; Zicker, Fabio] Fundacdo Oswaldo Cruz, CDTS, Rio De Janeiro, Brazil.
   [Girard-Dias, Wendell] Fundacdo Oswaldo Cruz, FIOCRUZ, Inst Oswaldo Cruz, Plataforma Microscopia Eletron Rudolf Barth, Rio De Janeiro, Brazil.
   [Girard-Dias, Wendell; de Souza, Wanderley; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, Rio De Janeiro, Brazil.
   [Girard-Dias, Wendell; de Souza, Wanderley; Miranda, Kildare] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, Brazil.
   [de Souza, Wanderley; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, Brazil.
   [Miranda, Kildare] Soc Brasileira Microscopia & Microanal, Rio De Janeiro, Brazil.
RP Miranda, K (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, Av Carlos Chagas Filho 373,Bloco G, BR-21941902 Rio de Janeiro, RJ, Brazil.; Fonseca, BDFE (corresponding author), Fiocruz MS, CDTS, Ave Brasil 4036,Room 814, BR-21040361 Rio De Janeiro, RJ, Brazil.
EM bruna.fonseca@cdts.fiocruz.br; kmiranda@biof.ufrj.br
RI Zicker, Fabio/I-4138-2012; Albuquerque, Priscila C/L-4884-2015; Zicker,
   Fabio/B-4209-2009
OI Albuquerque, Priscila C/0000-0001-8185-024X; Fonseca, Bruna de
   Paula/0000-0002-8795-2578; Zicker, Fabio/0000-0002-9751-7430
FU Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e
   Bioimagem (INBEB); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Financiadora
   de Estudos e Projetos (FINEP)Ciencia Tecnologia e Inovacao (FINEP);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX This work was supported by the Instituto Nacional de Ciencia e
   Tecnologia em Biologia Estrutural e Bioimagem (INBEB) and by grants from
   the following Brazilian agencies: Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Financiadora de Estudos
   e Projetos (FINEP) and financed in part by the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance
   Code 001. The authors thank Carl Zeiss do Brasil, Hitachi High
   Technologies, Jeol Brasil Instrumentos Cientificos, Tescan do Brasil,
   and Thermo Fisher Scientific for sharing information on the distribution
   of electron microscopes installed in the country. The authors also thank
   prof. Marcio Lourenco Rodrigues for his valuable contribution and
   encouragement during the initial stages of this work. The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Adams Jonathan, 2013, GLOBAL RES REPORT BU
   Amon Narciso de Barros, 2013, CAD EBAPE BR, V11, P256, DOI [10.1590/S1679-39512013000200005, DOI 10.1590/S1679-39512013000200005]
   [Anonymous], 2010, UNESCO SCI REP
   Bastian M, 2009, GEPHI OPEN SOURCE SO
   Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   Cardona M, 2005, SCIENTOMETRICS, V64, P313, DOI 10.1007/s11192-005-0253-8
   Barreto FCS, 2014, POLICY FUTURES EDUC, V12, P695, DOI 10.2304/pfie.2014.12.5.695
   Fonseca BDFE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181870
   Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0104-5
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Haguenau F, 2003, MICROSC MICROANAL, V9, P96, DOI 10.1017/SI431927603030113
   Jorio A, 2010, NAT MATER, V9, P528, DOI 10.1038/nmat2790
   Kitajima Elliot Watanabe, 2014, ANAIS ACAD PERNAMBUC, V4, P56
   Kostoff RN, 2008, J INFORMETR, V2, P354, DOI 10.1016/j.joi.2008.06.004
   Kothari A, 2014, SYST PRACT ACT RES, V27, P123, DOI 10.1007/s11213-012-9271-7
   Oldham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034368
   Oliveira ON, 2016, J PHYS CHEM C, V120, P5273, DOI 10.1021/acs.jpcc.6b01958
   Schimmel Gerhard, 1996, ADV IMAG ELECT PHYS, V96, P149, DOI [10.1016/S1076-5670(08)70041-7, DOI 10.1016/S1076-5670(08)70041-7]
   Schlegel Flavia, UNESCO SCI REP 2015
   Tan J, 2014, SCIENTOMETRICS, V98, P1473, DOI 10.1007/s11192-013-1125-2
   Vanderelst D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004266
   VANZ S. A. S., 2016, ENCONTROS BIBLI REV, V21, P41
   Veugelers Reinhilde, 2017, CHALLENGE CHINAS RIS, P16
   Waaijer CJF, 2015, ANAL CHEM, V87, P4588, DOI 10.1021/ac5040314
   Waltman Ludo, 2007, VOS NEW METHOD VISUA, P299, DOI [10.1007/978-3-540-70981-7_34, DOI 10.1007/978-3-540-70981-7_34]
   Xie Y, 2014, P NATL ACAD SCI USA, V111, P9437, DOI 10.1073/pnas.1407709111
NR 27
TC 2
Z9 2
U1 0
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD JAN
PY 2019
VL 116
BP 84
EP 92
DI 10.1016/j.micron.2018.10.005
PG 9
WC Microscopy
SC Microscopy
GA HD5JO
UT WOS:000452565500013
PM 30352362
DA 2020-11-10
ER

PT J
AU Vasconcellos, AG
   Fonseca, BDFE
   Morel, CM
AF Vasconcellos, Alexandre Guimaraes
   Fonseca e Fonseca, Bruna de Paula
   Morel, Carlos Medicis
TI Revisiting the concept of Innovative Developing Countries (IDCs) for its
   relevance to health innovation and neglected tropical diseases and for
   the prevention and control of epidemics
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; ZIKA VIRUS; SCIENTIFIC COLLABORATION; NETWORKS; BRAZIL;
   INFECTION; TRANSMISSION
AB Introduction
   Countries have traditionally been split into two major groups: developed or industrialized (<"the North) and developing or underdeveloped ("the South"). Several authors and organizations have challenged this classification to recognize countries that have reached an intermediate stage of social and economic development. As proposed by Morel and collaborators in 2005, the concept of Innovative Developing Countries (IDCs) defines a group of nations with impactful scientific programs. Here, IDCs are reexamined by a variety of metrics to highlight their role in health innovation through research and development (R&D) programs on neglected tropical diseases (NTDs) that also positively impact epidemic preparedness.
   Results
   To address the global changes due to expanding globalization we updated the original indicator of the number of USPTO patents deposited by individual countries per GDP and per capita to the number of international patents applications, related to applicant residence and deposited under the Patent Cooperation Treaty (PCT) per GNI (or GDP) and per capita. A comparison of the originally described ranking of top innovative countries to those in the present study revealed new members that updated the list of IDCs and showed a prominent role now played by China.
   Analyzing scientific publications in international journals since the introduction of the IDC concept in 2005 we found that IDCs do prioritize Neglected Tropical Diseases (NTDs) as an area of research.
   Finally we investigated the role of IDCs in two major public health emergencies between 2012 and 2016, the outbreaks of Ebola in West Africa and Zika in South America. An analysis of the co-authorship country networks demonstrated an important role for IDC infrastructure and personnel in the prevention and control of these epidemics.
   Discussion and conclusions
   Different techniques can be used to evaluate and measure innovative performance of countries. Country rankings published by traditional indexes, such as the Bloomberg Innovation Index (BII) and the Global Innovation Index (GII), only include high income economies among the top 20 performers. This is in sharp contrast to our approach, which identified 8-9 IDCs among the first 25 with China occupying the top position. Through an analysis of the pros and cons of the different methodologies, the IDC concept challenges more conventional approaches to address and estimate the innovative capacity of countries.
C1 [Vasconcellos, Alexandre Guimaraes] Natl Inst Ind Property INPI, Postgrad & Res Div, Rio De Janeiro, RJ, Brazil.
   [Fonseca e Fonseca, Bruna de Paula; Morel, Carlos Medicis] Oswaldo Cruz Fdn Fiocruz, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, Brazil.
RP Vasconcellos, AG (corresponding author), Natl Inst Ind Property INPI, Postgrad & Res Div, Rio De Janeiro, RJ, Brazil.; Morel, CM (corresponding author), Oswaldo Cruz Fdn Fiocruz, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, Brazil.
EM alexguim@inpi.gov.br; morel@cdts.fiocruz.br
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Fonseca, Bruna de Paula/0000-0002-8795-2578
FU Oswaldo Cruz Foundation (Fiocruz); National Council for Scientific and
   Technological Development (CNPq), Ministry of Science and
   TechnologyNational Council for Scientific and Technological Development
   (CNPq) [573642/2008-7, 465313/2014-0]; National Council for Scientific
   and Technological Development (CNPq), Ministry of Science and Technology
   (Productivity II Fellowship)National Council for Scientific and
   Technological Development (CNPq); Ministry of Education/CAPESCAPES
   [465313/2014-0]; Research Foundation of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [465313/2014-0]; CNPq postdoctoral fellowship
   at WIPO [202109/2015-1]
FX Funding was provided by the Oswaldo Cruz Foundation (Fiocruz); National
   Council for Scientific and Technological Development (CNPq), Ministry of
   Science and Technology (no. 573642/2008-7, 465313/2014-0 and
   Productivity II Fellowship to CMM); Ministry of Education/CAPES (no.
   465313/2014-0); Research Foundation of the State of Rio de Janeiro
   (FAPERJ) (no. 465313/2014-0) and CNPq postdoctoral fellowship at WIPO to
   AGV (202109/2015-1). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Access to Essential Medicines Campaign and the Drugs for Neglected Diseases Working Group, 2001, FAT IMB CRIS RES DEV
   [Anonymous], 2017, ECONOMIST
   Attaran A., 2016, HARVARD PUBLIC HLTH
   Baldwin R., 2016, GREAT CONVERGENCE IN
   Bastian M., 2009, 3 INT AAAI C WEBL SO
   Batallas DA, 2006, IEEE T ENG MANAGE, V53, P570, DOI 10.1109/TEM.2006.883706
   Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182
   Benoit Battistelli, 2017, EPO BLOG
   Bornmann L, 2015, J ASSOC INF SCI TECH, V66, P1507, DOI 10.1002/asi.23333
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burhan M, 2016, TECHNOLOGICAL FORECA
   Butler D., 2016, NATURE NEWS, V540, P507
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chan M., 2014, WHO DIRECTOR GEN BRI
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cornell University INSEAD and WIPO, 2017, GLOB INN IND 2017 IN
   Costa G, 2016, RIO 2016 FIC R 400 M
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   European Centre for Disease Prevention and Control, 2017, ZIK EP 2014 ONW
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0151-y
   FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gay B, 2005, RES POLICY, V34, P1457, DOI 10.1016/j.respol.2005.07.001
   Global Innovation Index, 2016, WINN GLOB INN
   Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581
   Hotez P., 2008, FORGOTTEN PEOPLE FOR
   Jamrisko M, 2017, THESE ARE WORLDS MOS
   Keating C., 2017, K WARREN GREAT NEGLE
   LONG JC, 2013, BMC HEALTH SERV RES, V13, P36569
   Ltd IC, 2017, BLOOMB INN IND REP
   Mahoney R., 2005, INNOVATION STRATEGY, V1, P33
   Mahoney RT, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-33
   Mahoney RT, 2006, INNOVATION STRATEGY, V2, P1
   MAHONEY RT, 2006, GLOBAL FORUM UPDATE, V3, P149
   MASHELKAR RA, 2005, INNOVATION STRATEGY, V1, P16
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Morel C, 2005, INNOVATION STRATEGY, V1, P1
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Morel CM, 2003, EMBO REP, V4, pS35, DOI 10.1038/sj.embor.embor851
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898
   Nilsson A., 2013, THESIS
   OECD E., 2005, OSL MAN GUID COLL IN, P46
   Phillips K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002568
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Scott JP, 2000, SOCIAL NETWORK ANALY, DOI [10.2307/3033543, DOI 10.2307/3033543]
   Tavernise S., 2016, NO ZIKA CASES REPORT
   Uniting to Combat Neglected Tropical Diseases, 2012, LOND DECL
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Vollmer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057624
   Warren K. S., 1986, ORPHAN DIS ORPHAN DR, P169
   WHO, 2016, WHO PUBL HLTH ADV RE
   WHO, 2001, MACROECONOMICS HLTH
   WHO (World Health Organization), 2012, WHOHTMNTD20121
   Wike R, 2017, MORE NAME US CHINA W
   WIPO, 2017, INT PAT CLASS FREQ A
   WIPO, 2017, INT PAT CLASS IPC
   WIPO, 2016, WIPO FACTS FIG TOT A
   World Bank Group, 2016, WORLD DEV IND 2016
   World Health Organization, 2013, NEGLECTED TROPICAL D
   World Health Organization, 2005, WHOCDSCPECEE200554
   World Health Organization, 2014, STAT 1 M IHRE EM COM
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 72
TC 4
Z9 4
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006469
DI 10.1371/journal.pntd.0006469
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700003
PM 30001318
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU Fonseca, BDFE
   Albuquerque, PC
   Noyons, E
   Zicker, F
AF Fonseca e Fonseca, Bruna de Paula
   Albuquerque, Priscila Costa
   Noyons, Ed
   Zicker, Fabio
TI South-south collaboration on HIV/AIDS prevention and treatment research:
   when birds of a feather rarely flock together
SO GLOBALIZATION AND HEALTH
LA English
DT Article
DE South-south collaboration; Co-authorship; HIV; Low- and middle-income
   countries; Scientific collaboration
ID COST-EFFECTIVENESS; MALE CIRCUMCISION; HIV PREVENTION; HEALTH; CAPACITY;
   SCIENCE; KENYA
AB Background: South-south collaboration on health and development research is a critical mechanism for social and economic progress. It allows sharing and replicating experiences to find a "southern solution" to meet shared health challenges, such as access to adequate HIV/AIDS prevention and treatment. This study aimed to generate evidence on the dynamics of south-south collaboration in HIV/AIDS research, which could ultimately inform stakeholders on the progress and nature of collaboration towards increased research capacities in low-and middle-income countries (LMIC).
   Methods: Bibliometric and social network analysis methods were used to assess the 10-year (2006-2015) scientific contribution of LMIC, through the analysis of scientific publications on HIV/AIDS prevention and/or treatment. Five dimensions oriented the study: knowledge production, co-authorship analysis, research themes mapping, research types classification and funding sources.
   Results: Publications involving LMIC have substantially increased overtime, despite small expression of south-south collaboration. Research themes mapping revealed that publication focus varied according to collaborating countries' income categories, from diagnosis, opportunistic infections and laboratory-based research (LMIC single or LMIC-LMIC) to human behavior and healthcare, drug therapy and mother to child transmission (LMIC-HIC). The analysis of research types showed that south-south collaborations frequently targeted social sciences issues. Funding agencies acknowledged in south-south collaboration also showed diverse focus: LMIC-based funders tended to support basic biomedical research whereas international/HIC-based funders seem to cover predominantly social sciences-oriented research.
   Conclusions: Although the global environment has fostered an increasing participation of LMIC in collaborative learning models, south-south collaboration on HIV/AIDS prevention and/or treatment research seemed to be lower than expected, stressing the need for strategies to foster these partnerships. The evidence presented in this study can be used to strengthen a knowledge platform to inform future policy, planning and funding decisions, contributing to the development of enhanced collaboration and a priority research agenda for LMICs.
C1 [Fonseca e Fonseca, Bruna de Paula; Albuquerque, Priscila Costa; Zicker, Fabio] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Av Brasil 4036,8th Floor,Room 814, BR-21040361 Rio De Janeiro, Brazil.
   [Noyons, Ed] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands.
RP Fonseca, BDFE (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Av Brasil 4036,8th Floor,Room 814, BR-21040361 Rio De Janeiro, Brazil.
EM bfonseca@cdts.fiocruz.br
RI Albuquerque, Priscila C/L-4884-2015; Zicker, Fabio/I-4138-2012; Zicker,
   Fabio/B-4209-2009
OI Albuquerque, Priscila C/0000-0001-8185-024X; Noyons,
   Ed/0000-0002-3103-2991; Fonseca, Bruna de Paula/0000-0002-8795-2578;
   Zicker, Fabio/0000-0002-9751-7430
FU Brazilian National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [458100/2014-15, 440231/2015-9]
FX This work was supported by the Brazilian National Counsel of
   Technological and Scientific Development (CNPq), grants # 458100/2014-15
   and 440231/2015-9.
CR Adcock J, 2008, GLOBAL HEALTH ACTION, V1, DOI 10.3402/gha.v1i0.1865
   Alonso J.A., 2015, WHAT IS DEV COOPERAT
   Arunachalam S, 2008, CURR SCI INDIA, V95, P311
   Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2
   Bastian M., 2009, 3 INT AAAI C WEBL SO
   Boshoff N, 2009, SCIENTOMETRICS, V81, P413, DOI 10.1007/s11192-008-2211-8
   Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243
   COHRED, 2012, RES INN KEY DRIV HLT
   Dean L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018718
   ECOSOC, 2016, TRENDS PROGR INT DEV
   ESSENCE on Health Research, 2014, 7 PRINC STRENGTH RES
   Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0104-5
   GFHR, 2004, 10 90 REP HLTH RES 2
   Gok A, 2016, J ASSOC INF SCI TECH, V67, P715, DOI 10.1002/asi.23406
   Gonzalez-Alcaide G, 2012, SCIENTOMETRICS, V92, P297, DOI 10.1007/s11192-012-0692-y
   Gonzalez-Brambila CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151328
   Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9
   Grossman CI, 2016, TRENDS MICROBIOL, V24, P5, DOI 10.1016/j.tim.2015.10.011
   Gupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022730
   Hanney SR, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-47
   Harmer A, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-15
   Holmqvist G., 2009, WORKING PAPER
   Ivers LC, 2010, AIDS, V24, pS73, DOI 10.1097/01.aids.0000366085.14064.6f
   Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517
   KIPPAX Susan, 2012, J INT AIDS SOC, V15
   Landini F, 2015, SCIENTOMETRICS, V105, P1787, DOI 10.1007/s11192-015-1635-1
   Langer A, 2004, B WORLD HEALTH ORGAN, V82, P802
   Leydesdorff L, 2008, J INFORMETR, V2, P317, DOI 10.1016/j.joi.2008.07.003
   Li LL, 2009, SCIENTOMETRICS, V80, P39, DOI 10.1007/s11192-008-1939-5
   Lorenzo C, 2008, REV BRASILEIRA BIOET, V4, P156
   McGregor S, 2015, LANCET GLOB HEALTH, V3, pE18, DOI 10.1016/S2214-109X(14)70352-3
   Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600
   Meneghini R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003804
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, pe501, DOI DOI 10.1371/J0URNAL.PNTD.0000501
   Nino F. S., SUSTAINABLE DEV GOAL
   Pang T, 2003, B WORLD HEALTH ORGAN, V81, P815
   Pouris A, 2014, SCIENTOMETRICS, V98, P2169, DOI 10.1007/s11192-013-1156-8
   Rodrigues ML, 2016, MBIO, V7, DOI 10.1128/mBio.00907-16
   SAGASTI F, 2004, KNOWLEDGE INNOVATION
   Salager-Meyer F., 2008, J ENGL ACAD PURP, V7, P121, DOI [10.1016/j.jeap.2008.03.009, DOI 10.1016/J.JEAP.2008.03.009]
   Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2
   Smith E, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-42
   Sridhar D., 2012, PLOS MED, P9
   Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8
   Syed SB, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-36
   Syed SB, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-17
   Terry RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-25
   The World Bank, WORLD BANK COUNTR LE
   Thorsteinsdottir H, 2010, NAT BIOTECHNOL, V28, P407, DOI 10.1038/nbt0510-407
   Uddin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123537
   UNAIDS, 2016, GLOB AIDS UPD 2016
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   van Eck NJ, 2009, J AM SOC INF SCI TEC, V60, P1635, DOI 10.1002/asi.21075
   Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002
   WHO, 2014, S S TRIANG COOP HLTH
   Zdravkovic M, 2016, SCIENTOMETRICS, V108, P717, DOI 10.1007/s11192-016-1989-z
NR 56
TC 3
Z9 3
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1744-8603
J9 GLOBALIZATION HEALTH
JI Global. Health
PD MAR 1
PY 2018
VL 14
AR 25
DI 10.1186/s12992-018-0341-1
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FX9AN
UT WOS:000426387500003
PM 29490665
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU Fonseca, BDFE
   da Silva, MVP
   de Araujo, KM
   Sampaio, RB
   Moraes, MO
AF Fonseca e Fonseca, Bruna de Paula
   Pereira da Silva, Marcus Vinicius
   de Araujo, Kizi Mendonca
   Sampaio, Ricardo Barros
   Moraes, Milton Ozorio
TI Network analysis for science and technology management: Evidence from
   tuberculosis research in Fiocruz, Brazil
SO PLOS ONE
LA English
DT Article
ID SCIENTIFIC COLLABORATION; BIOTECHNOLOGY; INNOVATION
AB Collaborative networks are of great value for science and technology (S&T) institutions as a way of sharing, generating and disseminating new knowledge that could ultimately lead to innovations. Driven by the need to assess the contribution and effectiveness of these networks in informing S&T management, we explored the evolution and dynamics of tuberculosis scientific networks involving the Oswaldo Cruz Foundation (Fiocruz), the major public health S&T Institution in Brazil. Social network analysis (SNA) was used to produce a 10-year (2005-2009, 2010-2014) retrospective longitudinal mapping of Brazilian tuberculosis research networks within the country and internationally, highlighting Fiocruz collaborations. Co-authorship analysis showed a significant expansion of collaboration in Brazil and the role of Fiocruz and other leading national institutions in maintaining connectivity, facilitating knowledge exchange and reducing network vulnerability. It also identified influential researchers that can act as information leaders and support strategic decisions. When we focused on networks inside the institution, the analysis showed a clear discontinuation between the clinical and the public health research areas, which needs specific internal policies to improve collaborations since outcomes in TB are expected to provide better diagnostic tools and more effective treatments. The approach provides evidence to support S&T management by pinpointing: key central institutions maintaining network connectivity; most influential researchers that can act as advisors/experts for investment and induction policies; key Fiocruz researchers that could improve information exchange, systems integration and innovation within the institution; opportunities for synergy between internal research groups working in complementary areas. In summary, we observed that SNA parameters proved to be a valuable tool that, along with other indicators, can strengthen knowledge platforms to support S&T management efforts.
C1 [Fonseca e Fonseca, Bruna de Paula] Fiocruz MS, CDTS, Rio De Janeiro, Brazil.
   [Pereira da Silva, Marcus Vinicius] Fiocruz MS, COC, Rio De Janeiro, Brazil.
   [de Araujo, Kizi Mendonca] Fiocruz MS, Inst Informacao Cient & Tecnol Saude ICICT, Rio De Janeiro, Brazil.
   [Sampaio, Ricardo Barros] Fiocruz MS, Diretoria Reg Brasilia DIREB, Brasilia, DF, Brazil.
   [Moraes, Milton Ozorio] Fiocruz MS, Vice Presidencia Ensino Informacao & Comunicacao, Rio De Janeiro, Brazil.
   [Moraes, Milton Ozorio] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil.
RP Fonseca, BDFE (corresponding author), Fiocruz MS, CDTS, Rio De Janeiro, Brazil.
EM bfonseca@cdts.fiocruz.br
RI Moraes, Milton Ozorio/G-9753-2011; Pereira-Silva, Marcus
   Vinicius/AAD-8584-2020
OI Moraes, Milton Ozorio/0000-0003-2653-0037; Pereira-Silva, Marcus
   Vinicius/0000-0002-4135-4011; Fonseca, Bruna de
   Paula/0000-0002-8795-2578
FU Fiocruz
FX Fiocruz provided support in the form of salaries for authors BPFF and
   MOM, but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   'author contributions' section.
CR Abbasi A, 2011, ARXIV11116804PHYS
   Abramovsky L, 2011, J ECON GEOGR
   Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Bastian M., 2009, 3 INT AAAI C WEBL SO
   Bell GG, 2005, STRATEGIC MANAGE J, V26, P287, DOI 10.1002/smj.448
   Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   Borgatti S.P., 2002, UCINET WINDOWS SOFTW
   Brasil, 2012, ESTR NAC CIENC TECN
   Cassi L, 2008, ECON INNOV NEW TECH, V17, P663, DOI 10.1080/10438590701785603
   Cross R, 2002, CALIF MANAGE REV, V44, P25, DOI 10.2307/41166121
   D'Este P., 2012, J ECON GEOGR
   Daar AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-346
   Disis ML, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000421
   Fonseca BPF, 2016, SCI PUBLIC POLICY
   Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0151-y
   Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0104-5
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257
   Costa BMG, 2013, SCIENTOMETRICS, V95, P571, DOI 10.1007/s11192-012-0924-1
   Hancean MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113271
   Hara N, 2003, J AM SOC INF SCI TEC, V54, P952, DOI 10.1002/asi.10291
   He J, 2009, TECHNOL FORECAST SOC, V76, P91, DOI 10.1016/j.techfore.2008.03.020
   Kritski A, 2016, I HIG MED TROP, V15, pS35
   Kritski A, 2016, REV SOC BRAS MED TRO, V49, P135, DOI 10.1590/0037-8682-0330-2015
   Lee DH, 2012, SCIENTOMETRICS, V91, P925, DOI 10.1007/s11192-011-0602-8
   Lienhardt C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001965
   Luzar B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094429
   Mattsson P, 2015, Collaboration across Health Research and Medical Care: Healthy Collaboration, P13
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Phillips K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002568
   Sizemore CF, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.21
   Tsai WP, 2001, ACAD MANAGE J, V44, P996, DOI 10.2307/3069443
   Valente T. W., 2010, SOCIAL NETWORKS HLTH
   Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   van Eck NJ, 2009, J AM SOC INF SCI TEC, V60, P1635, DOI 10.1002/asi.21075
   Vanderelst D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004266
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   World Health Organisation, 2015, WHO GLOB TUB REP 201
   World Health Organization, 2015, GLOB ACT FRAM TB RES
NR 45
TC 3
Z9 3
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 8
PY 2017
VL 12
IS 8
AR e0181870
DI 10.1371/journal.pone.0181870
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC9EU
UT WOS:000407144700008
PM 28792514
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU Sampaio, RB
   Fonseca, BPF
   Bahulkar, A
   Szymanski, BK
AF Sampaio, Ricardo B.
   Fonseca, Bruna P. F.
   Bahulkar, Ashwin
   Szymanski, Boleslaw K.
TI Network analysis to support public health: evolution of collaboration
   among leishmaniasis researchers
SO SCIENTOMETRICS
LA English
DT Article; Proceedings Paper
CT 6th Global Tech Mining Conference
CY SEP, 2016
CL Valencia, SPAIN
DE Network analysis; Scientific collaboration; Lexical analysis; Link
   prediction; Leishmaniasis
ID NEGLECTED DISEASES; SCIENTIFIC PRODUCTIVITY; CUTANEOUS LEISHMANIASIS;
   LEADERSHIP; INNOVATION; CAPACITY; IMPACT
AB Databases on scientific publications are a well-known source for complex network analysis. The present work focuses on tracking evolution of collaboration amongst researchers on leishmaniasis, a neglected disease associated with poverty and very common in Brazil, India and many other countries in Latin America, Asia and Africa. Using SCOPUS and PubMed databases we have identified clusters of publications resulting from research areas and collaboration between countries. Based on the collaboration patterns, areas of research and their evolution over the past 35 years, we combined different methods in order to understand evolution in science. The methods took into consideration descriptive network analysis combined with lexical analysis of publications, and the collaboration patterns represented by links in network structure. The methods used country of the authors' publications, MeSH terms, and the collaboration patterns in seven five-year period collaboration network and publication networks snapshots as attributes. The results show that network analysis metrics can bring evidences of evolution of collaboration between different research groups within a specific research area and that those areas have subnetworks that influence collaboration structures and focus.
C1 [Sampaio, Ricardo B.; Fonseca, Bruna P. F.] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, RJ, Brazil.
   [Sampaio, Ricardo B.] Fiocruz MS, Diretoria Reg Brasilia, Brasilia, DF, Brazil.
   [Bahulkar, Ashwin; Szymanski, Boleslaw K.] Rensselaer Polytech Inst, Comp Sci, Troy, NY USA.
   [Szymanski, Boleslaw K.] Spoleczna Akad Nauk, Lodz, Poland.
RP Sampaio, RB (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, RJ, Brazil.; Sampaio, RB (corresponding author), Fiocruz MS, Diretoria Reg Brasilia, Brasilia, DF, Brazil.
EM rsampaio.br@gmail.com
RI Szymanski, Boleslaw K/A-9121-2009; Szymanski, Boleslaw K/O-1374-2017
OI Szymanski, Boleslaw K/0000-0002-0307-6743; Szymanski, Boleslaw
   K/0000-0002-0307-6743; Fonseca, Bruna de Paula/0000-0002-8795-2578
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJ (INCT-IDN) [573642/2008-7]; ARL (NS CTA)
   [W911NF-09-2-0053]
FX This paper was supported by CNPq, CAPES and FAPERJ (INCT-IDN
   #573642/2008-7) and by ARL (NS CTA Agreement #W911NF-09-2-0053).
CR Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a
   Al-Mutawakel K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-14
   Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Asilian A, 2004, INT J DERMATOL, V43, P736, DOI 10.1111/j.1365-4632.2004.02349.x
   Bahulkar A., 2016, IEEE ACM INT C ADV S, P1107, DOI [10.1109/ASONAM.2016.7752391, DOI 10.1109/ASONAM.2016.7752391]
   Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114
   Bastian M., 2009, 3 INT AAAI C WEBL SO
   Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182
   Bennett S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001081
   Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313
   Brasil, 2012, ESTR NAC CIENC TECN
   D'Andreta D, 2013, J HEALTH SERV RES PO, V18, P40, DOI 10.1177/1355819613499902
   de Carvalho PB, 2001, FITOTERAPIA, V72, P599, DOI 10.1016/S0367-326X(01)00301-X
   Duque RB, 2005, SOC STUD SCI, V35, P755, DOI 10.1177/0306312705053048
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   G-Finder, 2014, NEGL DIS RES DEV EM
   Gonzalez-Alcaide G, 2013, REV SOC BRAS MED TRO, V46, P719, DOI 10.1590/0037-8682-0207-2013
   Guarnaccia C, 2016, BLOOD TRANSFUS-ITALY, V14, P490, DOI 10.2450/2015.0048-15
   Guerrant RL, 1999, CLIN INFECT DIS, V28, P966, DOI 10.1086/514765
   Guler I, 2012, STRATEGIC MANAGE J, V33, P535, DOI 10.1002/smj.957
   Holmgren M, 2004, PLOS BIOL, V2, P10, DOI 10.1371/journal.pbio.0020001
   Kettler HE, 2001, B WORLD HEALTH ORGAN, V79, P742
   Khatami A, 2007, J AM ACAD DERMATOL, V57, P335, DOI 10.1016/j.jaad.2007.01.016
   Kuzmin Konstantin, 2016, Appl Netw Sci, V1, P11, DOI 10.1007/s41109-016-0015-y
   Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359
   Leydesdorff L., 2009, ARXIV09111438PHYSICS
   Mckew JC, 2013, TRENDS PHARMACOL SCI, V34, P87, DOI 10.1016/j.tips.2012.10.001
   Morel CM, 2007, NATURE, V449, P180, DOI 10.1038/449180a
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Phillips K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002568
   Ramos JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-55
   Reinert M, 1986, CAHIERS ANAL DONNEES, V11, P471
   Reinert M., 1983, CAH ANAL DONNEES, V8, P187
   Rodrigues M. M., 2015, INT ARCH MED, DOI [10.3823/1853, DOI 10.3823/1853]
   Sampaio R. B., 2015, TEMPUS ACTAS SAUDE C, V9, P249, DOI 10.18569/tempus.v9i3.1800
   Singh Om Prakash, 2016, Lancet Infect Dis, V16, pe304, DOI 10.1016/S1473-3099(16)30140-2
   Souza MA, 2013, GLYCOCONJUGATE J, V30, P641, DOI 10.1007/s10719-012-9464-4
   Srivastava S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1553-y
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Weina PJ, 2004, CLIN INFECT DIS, V39, P1674, DOI 10.1086/425747
   Wilson K., 2011, PREVENTING CHRONIC D, V8
   World Health Organ, 2010, TECH REP SER, pxii
NR 44
TC 0
Z9 0
U1 0
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0138-9130
EI 1588-2861
J9 SCIENTOMETRICS
JI Scientometrics
PD JUN
PY 2017
VL 111
IS 3
BP 2001
EP 2021
DI 10.1007/s11192-017-2346-6
PG 21
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA EV4RE
UT WOS:000401747900043
DA 2020-11-10
ER

PT J
AU Mota, FB
   Fonseca, BDFE
   Galina, AC
   da Silva, RM
AF Mota, Fabio Batista
   Fonseca e Fonseca, Bruna de Paula
   Galina, Andreia Cristina
   da Silva, Roseli Monteiro
TI Mapping the dengue scientific landscape worldwide: a bibliometric and
   network analysis
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; scientific publications; scientific landscape; bibliometrics;
   social network analysis
ID PUBLIC-HEALTH; SCIENCE
AB BACKGROUND Despite the current global trend of reduction in the morbidity and mortality of neglected diseases, dengue's incidence has increased and occurrence areas have expanded. Dengue also persists as a scientific and technological challenge since there is no effective treatment, vaccine, vector control or public health intervention. Combining bibliometrics and social network analysis methods can support the mapping of dengue research and development (R&D) activities worldwide.
   OBJECTIVES The aim of this paper is to map the scientific scenario related to dengue research worldwide.
   METHODS We use scientific publication data from Web of Science Core Collection - articles indexed in Science Citation Index Expanded (SCI-EXPANDED) - and combine bibliometrics and social network analysis techniques to identify the most relevant journals, scientific references, research areas, countries and research organisations in the dengue scientific landscape.
   FINDINGS Our results show a significant increase of dengue publications over time; tropical medicine and virology as the most frequent research areas and biochemistry and molecular biology as the most central area in the network; USA and Brazil as the most productive countries; and Mahidol University and Fundacao Oswaldo Cruz as the main research organisations and the Centres for Disease Control and Prevention as the most central organisation in the collaboration network.
   MAIN CONCLUSIONS Our findings can be used to strengthen a global knowledge platform guiding policy, planning and funding decisions as well as to providing directions to researchers and institutions. So that, by offering to the scientific community, policy makers and public health practitioners a mapping of the dengue scientific landscape, this paper has aimed to contribute to upcoming debates, decision-making and planning on dengue R& D and public health strategies worldwide.
C1 [Mota, Fabio Batista; Galina, Andreia Cristina] Fdn Oswaldo Cruz Fiocruz, Pesquisa & Lab Referencia, Rio De Janeiro, RJ, Brazil.
   [Fonseca e Fonseca, Bruna de Paula; da Silva, Roseli Monteiro] Fdn Oswaldo Cruz Fiocruz, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, RJ, Brazil.
RP Mota, FB (corresponding author), Fdn Oswaldo Cruz Fiocruz, Pesquisa & Lab Referencia, Rio De Janeiro, RJ, Brazil.
EM fabiobmota@outlook.com
RI Galina, Andreia C/N-1863-2016; Galina, Andreia/AAD-1100-2019; Mota,
   Fabio B/G-3164-2015; Mota, Fabio/AAQ-7019-2020
OI Galina, Andreia C/0000-0002-3670-9172; Galina,
   Andreia/0000-0002-3670-9172; Mota, Fabio B/0000-0003-2401-7336; Mota,
   Fabio/0000-0003-2401-7336; Fonseca, Bruna de Paula/0000-0002-8795-2578
CR Abramovsky L, 2011, J ECON GEOGR, V11, P949, DOI 10.1093/jeg/lbq052
   Beaumier CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002448
   Bell GG, 2005, STRATEGIC MANAGE J, V26, P287, DOI 10.1002/smj.448
   Bhardwaj Raj Kumar, 2014, SRELS Journal of Information Management, V51, P77
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Breschi S., 2005, ANN EC STAT, V79, P189, DOI DOI 10.2307/20777575
   Brown A, 2011, SE ASIAN J TROP MED, V42, P477
   Bundschuh M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-331
   Dutt B, 2010, COLLNET J SCIENTOMET, V4, P81, DOI 10.1080/09737766.2010.10700885
   Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0104-5
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Gibbons RV, 2012, EMERG INFECT DIS, V18, P623, DOI 10.3201/eid1804.110134
   Gonzalez-Albo B, 2011, J INFORMETR, V5, P369, DOI 10.1016/j.joi.2011.01.011
   Halstead SB, 1988, J CHALL MOL BIO, V239, P476, DOI DOI 10.1126/SCIENCE.3277268
   Horstick O, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003632
   Kothari A, 2014, SYST PRACT ACT RES, V27, P123, DOI 10.1007/s11213-012-9271-7
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Munoz-Urbano Marcela, 2014, Recent Pat Antiinfect Drug Discov, V9, P209
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Noyons E, 2001, SCIENTOMETRICS, V50, P83, DOI 10.1023/A:1005694202977
   Thirumagal A, 2015, SRELS J INF MANAG, V52, P269
   Thisyakorn U, 2013, THER ADV VACCINES, V2, P3
   Thorsteinsdottir H, 2004, NAT BIOTECHNOL, V22, pDC3, DOI 10.1038/nbt1204supp-DC3
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Vera-Polania F, 2015, J INFECT PUBLIC HEAL, V8, P386, DOI 10.1016/j.jiph.2015.03.006
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 29
TC 3
Z9 3
U1 1
U2 40
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2017
VL 112
IS 5
BP 354
EP 363
DI 10.1590/0074-02760160423
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA ET3EG
UT WOS:000400159600005
PM 28443981
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU Fonseca, BPF
   Fernandes, E
   Fonseca, MVA
AF Fonseca, Bruna P. F.
   Fernandes, Elton
   Fonseca, Marcus V. A.
TI Collaboration in science and technology organizations of the public
   sector: A network perspective
SO SCIENCE AND PUBLIC POLICY
LA English
DT Article
DE networks; collaboration; R & D; public sector; indicators; Brazil
ID PRODUCT DEVELOPMENT; SCIENTIFIC COLLABORATION; COAUTHORSHIP NETWORKS;
   INNOVATION NETWORKS; HEALTH; PERFORMANCE; EXPLORATION; IMPACT;
   BIOTECHNOLOGY; EXPLOITATION
AB Engaging in collaborative networks can be an important facilitator of innovation for public sector science and technology (S&T) organizations. It is also an important component of S&T policies that require indicators that can assess the networks through which these organizations innovate. In this study, we apply network indicators to two S&T organizations that are part of the Brazilian public health sector. The indicators cover two complementary perspectives: one that considers the organizations' scientific networks and the other that considers their technological networks. The indicators allowed the analysis of the networks in which the organizations were engaged and the understanding of important aspects of their collaboration patterns that can support strategic decisions. The method employed in this paper proved to be a valuable diagnostic tool and a useful mechanism for evaluating the performance and supporting the development of S&T institutions.
C1 [Fonseca, Bruna P. F.; Fernandes, Elton; Fonseca, Marcus V. A.] Univ Fed Rio de Janeiro, Alberto Luiz Coimbra Inst Grad Studies & Res Engn, Ctr Tecnol, Cidade Univ,Bloco F Sala 103, Rio De Janeiro, RJ, Brazil.
   [Fonseca, Bruna P. F.] Fiocruz MS, Oswaldo Cruz Fdn, Ctr Technol Dev Hlth CDTS, Av Brasil,4036 Predio Expansao 8 Andar,Sala 814, Rio De Janeiro, RJ, Brazil.
RP Fonseca, BPF (corresponding author), Univ Fed Rio de Janeiro, Alberto Luiz Coimbra Inst Grad Studies & Res Engn, Ctr Tecnol, Cidade Univ,Bloco F Sala 103, Rio De Janeiro, RJ, Brazil.; Fonseca, BPF (corresponding author), Fiocruz MS, Oswaldo Cruz Fdn, Ctr Technol Dev Hlth CDTS, Av Brasil,4036 Predio Expansao 8 Andar,Sala 814, Rio De Janeiro, RJ, Brazil.
EM bfonseca@cdts.fiocruz.br
RI Fernandes, Elton/I-2908-2017; de Araujo Fonseca, Marcus
   Vinicius/AAF-5791-2019
OI Fernandes, Elton/0000-0001-9340-8547; de Araujo Fonseca, Marcus
   Vinicius/0000-0001-6177-1966; Fonseca, Bruna de
   Paula/0000-0002-8795-2578
CR Abramovsky L, 2011, J ECON GEOGR, V11, P949, DOI 10.1093/jeg/lbq052
   Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a
   Alcará Adriana Rosecler, 2006, Transinformação, V18, P143
   Atuahene-Gima K, 2005, J MARKETING, V69, P61, DOI 10.1509/jmkg.2005.69.4.61
   Balconi M, 2004, RES POLICY, V33, P127, DOI 10.1016/S0048-7333(03)00108-2
   Bastian M., 2009, P INT AAAI C WEBL SO, V8, P361, DOI DOI 10.1136/QSHC.2004.010033
   Batallas DA, 2006, IEEE T ENG MANAGE, V53, P570, DOI 10.1109/TEM.2006.883706
   Baum JAC, 2000, STRATEGIC MANAGE J, V21, P267, DOI 10.1002/(SICI)1097-0266(200003)21:3<267::AID-SMJ89>3.0.CO;2-8
   Beaudry C, 2011, EUR MANAG J, V29, P362, DOI 10.1016/j.emj.2011.03.001
   Beaver DD, 2001, SCIENTOMETRICS, V52, P365, DOI 10.1023/A:1014254214337
   Bommert B., 2010, INT PUBLIC MANAG J, V11, P15, DOI DOI 10.1017/CBO9781316105337.006
   Boschma RA, 2005, REG STUD, V39, P61, DOI 10.1080/0034340052000320887
   Breschi S., 2005, ANN EC STAT, V79, P189, DOI DOI 10.2307/20777575
   Breschi S, 2010, RES POLICY, V39, P14, DOI 10.1016/j.respol.2009.11.004
   Choe H, 2013, RENEW SUST ENERG REV, V26, P492, DOI 10.1016/j.rser.2013.05.037
   D'Este P, 2013, J ECON GEOGR, V13, P537, DOI 10.1093/jeg/lbs010
   De Franco M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002862
   Eslami H, 2013, SCIENTOMETRICS, V97, P99, DOI 10.1007/s11192-013-1069-6
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Gadelha Carlos, 2003, Hist. cienc. saude-Manguinhos, V10, P697, DOI 10.1590/S0104-59702003000500012
   Gamal D., 2011, MEASURE ORG INNOVATI
   Giuliani E, 2011, SOCIAL NETWORK ANAL
   Glanzel W, 2005, HDB QUANTITATIVE SCI, P257, DOI DOI 10.1007/1-4020-2755-9
   Gonzalez-Alcaide G, 2013, REV SOC BRAS MED TRO, V46, P719, DOI 10.1590/0037-8682-0207-2013
   Gadelha CAG, 2012, REV SAUDE PUBL, V46, P13, DOI 10.1590/s0034-89102012005000062
   Guler I, 2012, STRATEGIC MANAGE J, V33, P535, DOI 10.1002/smj.957
   Haeussler C, 2012, J BUS VENTURING, V27, P217, DOI 10.1016/j.jbusvent.2010.10.002
   Hagedoorn J, 2002, ORGAN STUD, V23, P525, DOI 10.1177/0170840602234002
   He J, 2009, TECHNOL FORECAST SOC, V76, P91, DOI 10.1016/j.techfore.2008.03.020
   Hoang H, 2005, ACAD MANAGE J, V48, P332, DOI 10.5465/AMJ.2005.16928417
   Knoben J, 2006, INT J MANAG REV, V8, P71, DOI 10.1111/j.1468-2370.2006.00121.x
   Lavie D, 2011, ORGAN SCI, V22, P1517, DOI 10.1287/orsc.1100.0596
   Lee DH, 2012, SCIENTOMETRICS, V91, P925, DOI 10.1007/s11192-011-0602-8
   Leischow SJ, 2008, AM J PREV MED, V35, pS196, DOI 10.1016/j.amepre.2008.05.014
   Li EY, 2013, RES POLICY, V42, P1515, DOI 10.1016/j.respol.2013.06.012
   March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71
   Marsan G. A, 2012, OECD REGIONAL DEV WO
   Martins WD, 2012, REV SAUDE PUBL, V46, P51, DOI 10.1590/S0034-89102012005000057
   Mays GP, 2010, PREV CHRONIC DIS, V7
   Melese T, 2009, NAT MED, V15, P502, DOI 10.1038/nm0509-502
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Murray F, 2002, RES POLICY, V31, P1389, DOI 10.1016/S0048-7333(02)00070-7
   Netherlands Observatory of Science and Technology, 2010, SCI TECHN IND REP 20
   Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Nooteboom B, 2007, RES POLICY, V36, P1016, DOI 10.1016/j.respol.2007.04.003
   Organisation for Economic Co-operation and Development, 2005, MEAS SCI TECHN ACT G
   Ozcan S, 2014, TECHNOL FORECAST SOC, V82, P115, DOI 10.1016/j.techfore.2013.08.008
   Powell W. W, 2002, READINGS EC SOCIOLOG, P262
   Ramesh B, 1999, DECIS SUPPORT SYST, V27, P213, DOI 10.1016/S0167-9236(99)00045-7
   Reagans R, 2001, ORGAN SCI, V12, P502, DOI 10.1287/orsc.12.4.502.10637
   Rothaermel FT, 2004, STRATEGIC MANAGE J, V25, P201, DOI 10.1002/smj.376
   Schilling MA, 2007, MANAGE SCI, V53, P1113, DOI 10.1287/mnsc.1060.0624
   SCOTT J, 2001, SOCIAL NETWORK ANAL
   Shipilov A, 2014, ACAD MANAGE J, V57, P449, DOI 10.5465/amj.2013.1145
   Ter Wal ALJ, 2013, REG STUD, V47, P651, DOI 10.1080/00343401003614258
   The Royal Society, 2011, 0311 RS
   Toole AA, 2012, RES POLICY, V41, P1, DOI 10.1016/j.respol.2011.06.004
   Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Wagner CS, 2005, RES POLICY, V34, P1608, DOI 10.1016/j.respol.2005.08.002
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Yamakawa Y, 2011, RES POLICY, V40, P287, DOI 10.1016/j.respol.2010.10.006
   Yang CH, 2014, SCI PUBL POLICY, V41, P734, DOI 10.1093/scipol/scu007
   Zaheer A, 2010, ACAD MANAGE PERSPECT, V24, P62, DOI 10.5465/AMP.2010.50304417
NR 66
TC 5
Z9 6
U1 2
U2 24
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0302-3427
EI 1471-5430
J9 SCI PUBL POLICY
JI Sci. Public Policy
PD FEB
PY 2017
VL 44
IS 1
BP 37
EP 49
DI 10.1093/scipol/scw013
PG 13
WC Environmental Studies; Management; Public Administration
SC Environmental Sciences & Ecology; Business & Economics; Public
   Administration
GA EP0OG
UT WOS:000397086000004
DA 2020-11-10
ER

PT J
AU Fonseca, BDFE
   Zicker, F
AF Fonseca e Fonseca, Bruna de Paula
   Zicker, Fabio
TI Dengue research networks: building evidence for policy and planning in
   Brazil
SO HEALTH RESEARCH POLICY AND SYSTEMS
LA English
DT Article
DE Research networks; Policy and planning; Dengue; Social network analysis
ID NEGLECTED DISEASES; GLOBAL HEALTH; COLLABORATION; INNOVATION; EVOLUTION
AB Background: The analysis of scientific networks has been applied in health research to map and measure relationships between researchers and institutions, describing collaboration structures, individual roles, and research outputs, and helping the identification of knowledge gaps and cooperation opportunities. Driven by dengue continued expansion in Brazil, we explore the contribution, dynamics and consolidation of dengue scientific networks that could ultimately inform the prioritisation of research, financial investments and health policy.
   Method: Social network analysis (SNA) was used to produce a 20-year (1995-2014) retrospective longitudinal evaluation of dengue research networks within Brazil and with its partners abroad, with special interest in describing institutional collaboration and their research outputs.
   Results: The analysis of institutional co-authorship showed a significant expansion of collaboration over the years, increased international involvement, and ensured a shift from public health research toward vector control and basic biomedical research, probably as a reflection of the expansion of transmission, high burden and increasing research funds from the Brazilian government. The analysis identified leading national organisations that maintained the research network connectivity, facilitated knowledge exchange and reduced network vulnerability.
   Conclusions: SNA proved to be a valuable tool that, along with other indicators, can strengthen a knowledge platform to inform future policy, planning and funding decisions. The paper provides relevant information to policy and planning for dengue research as it reveals: (1) the effectiveness of the research network in knowledge generation, sharing and diffusion; (2) the near-absence of collaboration with the private sector; and (3) the key central organisations that can support strategic decisions on investments, development and implementation of innovations. In addition, the increase in research activities and collaboration has not yet significantly affected dengue transmission, suggesting a limited translation of research efforts into public health solutions.
C1 [Fonseca e Fonseca, Bruna de Paula; Zicker, Fabio] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Ave Brasil 4036,8th Floor,Room 814, BR-21040361 Rio De Janeiro, Brazil.
RP Fonseca, BDFE (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Ave Brasil 4036,8th Floor,Room 814, BR-21040361 Rio De Janeiro, Brazil.
EM bfonseca@cdts.fiocruz.br
RI Zicker, Fabio/I-4138-2012; Zicker, Fabio/B-4209-2009
OI Zicker, Fabio/0000-0002-9751-7430; Fonseca, Bruna de
   Paula/0000-0002-8795-2578
FU Brazilian National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [458100/2014-15]
FX This work was supported by the Brazilian National Counsel of
   Technological and Scientific Development (CNPq), grant # 458100/2014-15.
CR Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a
   Bastian M., 2009, P INT AAAI C WEBL SO, V8, P361, DOI DOI 10.1136/QSHC.2004.010033
   Bell GG, 2005, STRATEGIC MANAGE J, V26, P287, DOI 10.1002/smj.448
   Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brazil Department of Science and Technology, 2010, REV SAUDE PUBL, V44, P1159
   Dalglish SL, 2015, HEALTH POLICY PLANN, V30, P12, DOI 10.1093/heapol/czv043
   Eslami H, 2013, SCIENTOMETRICS, V97, P99, DOI 10.1007/s11192-013-1069-6
   Fonseca BPF, 2017, SCI PUBL POLICY, V44, P37, DOI 10.1093/scipol/scw013
   Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0104-5
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Gonzalez-Alcaide G, 2013, REV SOC BRAS MED TRO, V46, P719, DOI 10.1590/0037-8682-0207-2013
   Gonzalez-Alcaide G, 2012, REV INST MED TROP SP, V54, P219, DOI 10.1590/S0036-46652012000400007
   Guimarães Reinaldo, 2004, Ciênc. saúde coletiva, V9, P375, DOI 10.1590/S1413-81232004000200014
   Haythornthwaite C., 1996, LIB INFORM SCI RES, V18, P323, DOI DOI 10.1016/S0740-8188(96)90003-1
   He J, 2009, TECHNOL FORECAST SOC, V76, P91, DOI 10.1016/j.techfore.2008.03.020
   Horstick O, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003632
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Kshitij A, 2015, SCIENTOMETRICS, V102, P285, DOI 10.1007/s11192-014-1310-y
   Lee DH, 2012, SCIENTOMETRICS, V91, P925, DOI 10.1007/s11192-011-0602-8
   Leischow SJ, 2008, AM J PREV MED, V35, pS196, DOI 10.1016/j.amepre.2008.05.014
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Phillips K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002568
   Protogerou A, 2010, SCI PUBL POLICY, V37, P283, DOI 10.3152/030234210X496637
   Shiffman J, 2016, HEALTH POLICY PLANN, V31, P110, DOI 10.1093/heapol/czw012
   The Royal Society, 2011, 0311 RS
   Utzinger J, 2013, ACTA TROP, V128, P182, DOI 10.1016/j.actatropica.2013.08.011
   Valente T. W., 2010, SOCIAL NETWORKS HLTH
   Vanderelst D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004266
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Yang CH, 2014, SCI PUBL POLICY, V41, P734, DOI 10.1093/scipol/scu007
NR 33
TC 5
Z9 5
U1 0
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-4505
J9 HEALTH RES POLICY SY
JI Health Res. Policy Syst.
PD NOV 8
PY 2016
VL 14
AR 80
DI 10.1186/s12961-016-0151-y
PG 10
WC Health Policy & Services
SC Health Care Sciences & Services
GA EB5QA
UT WOS:000387434100001
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU Fonseca, BDFE
   Sampaio, RB
   Fonseca, MVD
   Zicker, F
AF Fonseca e Fonseca, Bruna de Paula
   Sampaio, Ricardo Barros
   de Araujo Fonseca, Marcus Vinicius
   Zicker, Fabio
TI Co-authorship network analysis in health research: method and potential
   use
SO HEALTH RESEARCH POLICY AND SYSTEMS
LA English
DT Review
ID SCIENTIFIC COLLABORATION; COAUTHORSHIP NETWORKS; INNOVATION NETWORKS;
   NEGLECTED DISEASES; PUBLIC-HEALTH; SMALL WORLDS; CHIKUNGUNYA;
   COMMUNITIES; MANAGEMENT; EVOLUTION
AB Scientific collaboration networks are a hallmark of contemporary academic research. Researchers are no longer independent players, but members of teams that bring together complementary skills and multidisciplinary approaches around common goals. Social network analysis and co-authorship networks are increasingly used as powerful tools to assess collaboration trends and to identify leading scientists and organizations. The analysis reveals the social structure of the networks by identifying actors and their connections. This article reviews the method and potential applications of co-authorship network analysis in health. The basic steps for conducting co-authorship studies in health research are described and common network metrics are presented. The application of the method is exemplified by an overview of the global research network for Chikungunya virus vaccines.
C1 [Fonseca e Fonseca, Bruna de Paula; de Araujo Fonseca, Marcus Vinicius] Fed Univ Rio de Janeiro UFRJ, Alberto Luiz Coimbra Inst Grad Studies & Res Engn, Ctr Technol, Ave Horacio Macedo 2030,Room G207, BR-21941914 Rio De Janeiro, Brazil.
   [Fonseca e Fonseca, Bruna de Paula; Zicker, Fabio] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Ave Brasil 4036,8th Floor,Room 814, BR-21040361 Rio De Janeiro, Brazil.
   [Sampaio, Ricardo Barros] Oswaldo Cruz Fdn Fiocruz, Diretoria Reg Brasilia DIREB, Ave L3 Norte S-N,Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil.
   [Sampaio, Ricardo Barros] Univ Brasilia, Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil.
RP Fonseca, BDFE (corresponding author), Fed Univ Rio de Janeiro UFRJ, Alberto Luiz Coimbra Inst Grad Studies & Res Engn, Ctr Technol, Ave Horacio Macedo 2030,Room G207, BR-21941914 Rio De Janeiro, Brazil.; Fonseca, BDFE (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Ave Brasil 4036,8th Floor,Room 814, BR-21040361 Rio De Janeiro, Brazil.
EM brufonseca@gmail.com
RI de Araujo Fonseca, Marcus Vinicius/AAF-5791-2019; Zicker,
   Fabio/I-4138-2012; Zicker, Fabio/B-4209-2009
OI de Araujo Fonseca, Marcus Vinicius/0000-0001-6177-1966; Fonseca, Bruna
   de Paula/0000-0002-8795-2578; Zicker, Fabio/0000-0002-9751-7430
CR Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a
   Agrawal A, 2006, J ECON GEOGR, V6, P571, DOI 10.1093/jeg/lbl016
   Alcará Adriana Rosecler, 2006, Transinformação, V18, P143
   Barbastefano Rafael Garcia, 2013, Perspect. ciênc. inf., V18, P78, DOI 10.1590/S1413-99362013000300006
   Bastian M, 2009, P 3 INT AAAI C WEB S
   Batagelj V, 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368
   Baum JAC, 2003, IND CORP CHANGE, V12, P697, DOI 10.1093/icc/12.4.697
   Beaver DD, 2001, SCIENTOMETRICS, V52, P365, DOI 10.1023/A:1014254214337
   Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182
   Borgatti S.P., 2002, UCINET WINDOWS SOFTW
   Breschi S., 2005, ANN EC STAT, V79, P189, DOI DOI 10.2307/20777575
   Dove A, 2015, NAT MED, V21, P1107, DOI 10.1038/nm1015-1107
   Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860
   Eslami H, 2013, SCIENTOMETRICS, V97, P99, DOI 10.1007/s11192-013-1069-6
   Fleming L, 2007, ORGAN SCI, V18, P938, DOI 10.1287/orsc.1070.0289
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   GELIJNS AC, 1995, MED INN CR, V5, P3
   Glanzel W, 2005, HDB QUANTITATIVE SCI, P257, DOI DOI 10.1007/1-4020-2755-9
   Costa BMG, 2013, SCIENTOMETRICS, V95, P571, DOI 10.1007/s11192-012-0924-1
   Gonzalez-Alcaide G, 2013, REV SOC BRAS MED TRO, V46, P719, DOI 10.1590/0037-8682-0207-2013
   Haythornthwaite C., 1996, LIB INFORM SCI RES, V18, P323, DOI DOI 10.1016/S0740-8188(96)90003-1
   He J, 2009, TECHNOL FORECAST SOC, V76, P91, DOI 10.1016/j.techfore.2008.03.020
   Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1
   Lander B, 2013, SCIENTOMETRICS, V94, P343, DOI 10.1007/s11192-012-0776-8
   Laudel G, 2002, RES EVALUAT, V11, P3, DOI 10.3152/147154402781776961
   Leischow SJ, 2008, AM J PREV MED, V35, pS196, DOI 10.1016/j.amepre.2008.05.014
   Martins WD, 2012, REV SAUDE PUBL, V46, P51, DOI 10.1590/S0034-89102012005000057
   McSweegan E, 2015, ANTIVIR RES, V120, P147, DOI 10.1016/j.antiviral.2015.06.003
   Melese T, 2009, NAT MED, V15, P502, DOI 10.1038/nm0509-502
   Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Naranjo-Estupinan NF, 2014, BIOMEDICA, V34, P300, DOI [10.7705/biomedica.v34i2.2127, 10.1590/S0120-41572014000200016]
   National Institute of Allergy and Infectious Diseases, EM INF DIS PATH
   Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Oon LLE, 2014, ANN ACAD MED SINGAP, V43, P325
   Robinson-Garcia N, 2013, REV ESP DOC CIENT, V36, DOI 10.3989/redc.2013.4.1042
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Sonnenwald DH, 2007, ANNU REV INFORM SCI, V41, P643, DOI 10.1002/aris.2007.1440410121
   The Royal Society, 2011, 0311 RS
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Utzinger J, 2013, ACTA TROP, V128, P182, DOI 10.1016/j.actatropica.2013.08.011
   Valente T. W., 2010, SOCIAL NETWORKS HLTH
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Wang DJ, 2012, SOC NETWORKS, V34, P396, DOI 10.1016/j.socnet.2012.01.003
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Yang CH, 2014, SCI PUBL POLICY, V41, P734, DOI 10.1093/scipol/scu007
   Zhang CC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-52
NR 50
TC 29
Z9 29
U1 0
U2 38
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-4505
J9 HEALTH RES POLICY SY
JI Health Res. Policy Syst.
PD APR 30
PY 2016
VL 14
AR 34
DI 10.1186/s12961-016-0104-5
PG 10
WC Health Policy & Services
SC Health Care Sciences & Services
GA DK8RA
UT WOS:000375194800001
PM 27138279
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU Sampaio, RB
   Sacerdote, HCD
   Fonseca, BDF
   Fernandes, JHC
AF Sampaio, Ricardo Barros
   de Souza Sacerdote, Helena Celia
   Fonseca Fonseca, Bruna de Paula
   Cabral Fernandes, Jorge Henrique
TI Scientific collaboration in co-authorship research: a method based on
   network analysis
SO PERSPECTIVAS EM CIENCIA DA INFORMACAO
LA Portuguese
DT Article
DE Co-authorship; Scientific collaboration; Network analysis
ID PATTERNS
AB This work presents a method to the study of scientific communication derived from network analysis methods. It has been analyzed the professional relationships of scientific collaboration between authors that use co-authoship, a new sub-area in scientific communication that has gained space in information science. In co-authorship, any two authors are defined as having a relationship if they have collaborated in the production of an article or scientific publication. This paper investigates whether this association allows the comprehension of the problems of scientific collaboration, for example, if knowledge is concentrated in a few countries or individuals, and how these individuals relate to each other. The methodology is based on the exploratory model proposed by Nooy, Mrvar e Batagelj (2011). From the point of view of bibliometrics, scientific collaborations were analyzed in the Web of Science database. The results obtained showed that the field of co-authorship spans several countries and different areas of interest. It is observed that the association of bibliometric methods and network analysis contributes to a better interpretation of the results, mainly through the visual inspection that network analysis methods are able to provide.
C1 [Sampaio, Ricardo Barros] Fundacao Oswaldo Cruz DIREB, Joao Pessoa, PB, Brazil.
   [de Souza Sacerdote, Helena Celia] Univ Brasilia, Fac Ciencia Informacao, BR-70910900 Brasilia, DF, Brazil.
   [Fonseca Fonseca, Bruna de Paula] Fundacao Oswaldo Cruz CDTS, Rio De Janeiro, Brazil.
   [Cabral Fernandes, Jorge Henrique] Univ Brasilia, Fac Ciencia Informacao, Programa Posgrad, Grp Pesquisa Inteligencia Cooperat Redes Sociais, BR-70910900 Brasilia, DF, Brazil.
RP Sampaio, RB (corresponding author), Fundacao Oswaldo Cruz DIREB, Joao Pessoa, PB, Brazil.
OI Fonseca, Bruna de Paula/0000-0002-8795-2578
CR BARABASI A. L., 2012, GRAPH THEORY
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   De Nooy W, 2011, EXPLORATORY SOCIAL N
   Glanzel W, 2002, LIBR TRENDS, V50, P461
   GLANZEL W., 2003, NORD J PSYCHIAT, V57, P393
   Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104
   Goyal S, 2006, J POLIT ECON, V114, P403, DOI 10.1086/500990
   Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1
   Laudel G, 2002, RES EVALUAT, V11, P3, DOI 10.3152/147154402781776961
   Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600
   Nagpaul PS, 2002, SCIENTOMETRICS, V54, P213, DOI 10.1023/A:1016036711279
   National Research Council Committee on Network Science for Future Army Applications, 2005, NETWORK SCI
   Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.066133, 10.1103/PhysRevE.69.026113]
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898
   Sonnenwald DH, 2007, ANNU REV INFORM SCI, V41, P643, DOI 10.1002/aris.2007.1440410121
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
NR 20
TC 3
Z9 4
U1 0
U2 24
PU UNIV FEDERAL MINAS GERAIS, ESCOLA BIBLIOTECONOMIA
PI BELO HORIZONTE
PA CENTRO, CAIXA POSTAL 1606, BELO HORIZONTE, MG 30161-970, BRAZIL
SN 1413-9936
EI 1981-5344
J9 PERSPECT CIENC INF
JI Pespect. Cienc. Inf.
PD OCT-DEC
PY 2015
VL 20
IS 4
BP 79
EP 92
DI 10.1590/1981-5344/2447
PG 14
WC Information Science & Library Science
SC Information Science & Library Science
GA DM7BQ
UT WOS:000376508300006
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU Barboza, BA
   Fonseca, BPF
   Viola, JPB
AF Barboza, Bianca A.
   Fonseca, Bruna P. F.
   Viola, Joao P. B.
TI NFAT1 transcription factor in dendritic cells is required to modulate T
   helper cell differentiation
SO IMMUNOBIOLOGY
LA English
DT Article
DE Cytokines; Dendritic cells; Lymphocyte differentiation; NFAT; Th1/Th2
   cells
ID IFN-GAMMA PRODUCTION; IMMUNE-RESPONSES; NUCLEAR FACTOR; ACTIVATION;
   INTERLEUKIN-12; PROMOTER; TH1; STIMULATION; EXPRESSION; INDUCTION
AB The NFAT family of transcription factors plays a central role in the regulation of cytokine gene expression during the immune response. NFAT functions have been extensively explored in lymphocyte activation and differentiation, but the involvement of NFAT proteins in dendritic cells (DCs) is still not well known. Here, we investigated the role of the NFAT1 transcription factor in murine DCs. Initially, we demonstrated by western blot that the NFAT1 protein is present in splenic DCs and is rapidly activated upon calcium influx. We then used NFAT1-deficient mice (NFAT1-/-) to investigate whether NFAT1 influences the ability of DCs to induce Th differentiation. Our data demonstrated that NFAT1-/- DCs showed an increased capacity to differentiate CD4 T cells to the Th1 phenotype. CD4 cells that were primed in vitro with NFAT1-/- DCs had increased IFN-gamma production. The same results were observed when the CD4 cells were primed in vivo through the sensitization of NFAT1-/- mice with ovalbumin. Furthermore, our results demonstrated that the cytokine IL-12 is one of the factors involved in this process because its production is increased in NFAT1-/- mice, and neutralizing anti-IL-12 antibodies almost completely eliminated the IFN-gamma, production. These results demonstrated that the NFAT1 transcription factor regulates specific functions in DCs that are involved in CD4 differentiation, suggesting that the inhibition of NFAT1 in DCs may be used as a therapy to modulate specific immune responses. (C) 2014 Elsevier GmbH. All rights reserved.
C1 [Barboza, Bianca A.; Fonseca, Bruna P. F.; Viola, Joao P. B.] Brazilian Natl Canc Inst INCA, Program Cellular Biol, Rio De Janeiro, Brazil.
RP Viola, JPB (corresponding author), Brazilian Natl Canc Inst INCA, Program Cellular Biol, Rua Andre Cavalcanti,37, Rio De Janeiro, Brazil.
EM jpviola@inca.gov.br
RI Viola, Joao/AAP-4125-2020
OI Viola, Joao/0000-0002-0698-3146; Fonseca, Bruna de
   Paula/0000-0002-8795-2578
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [478780/2010-9, 307296/2011-3]; Fundacao de Amparo a Pesquisa do Estado
   do Rio de JaneiroCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [102.357/2009]; Instituto Nacional
   de Ciencia e Tecnologia em Cancer [573806/2008-0, 170.026/2008];
   Brazilian Ministry of Health
FX We thank Dr. Marcelo T. Bozza and Dr. Patricia S. Araujo-Souza for
   critical reading of this manuscript. We are especially grateful to Dr.
   A. Rao for kindly providing the NFAT reagents and NFAT1-/- mice. We also
   thank Margot C. Canis and Natalia M. Lanzarini for technical assistance
   on DC purification and immunofluorescence analysis, respectively. This
   work was supported by grants to J.P.B.V. from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (478780/2010-9 and
   307296/2011-3), Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (102.357/2009) and Instituto Nacional de Ciencia e Tecnologia em
   Cancer (573806/2008-0 and 170.026/2008). B.A.B. and B.P.F.F. were
   supported by a Brazilian Ministry of Health fellowship.
CR Bagley KC, 2004, CLIN DIAGN LAB IMMUN, V11, P77, DOI 10.1128/CDLI.11.1.77-82.2004
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297
   Czerniecki BJ, 1997, J IMMUNOL, V159, P3823
   Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569
   Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107
   Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256
   Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Kayama H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000514
   Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3
   Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480
   Loh C, 1996, MOL CELL BIOL, V16, P3945
   MACATONIA SE, 1995, J IMMUNOL, V154, P5071
   Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632
   Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734
   Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641
   Rafiq K, 1998, EUR J IMMUNOL, V28, P1481, DOI 10.1002/(SICI)1521-4141(199805)28:05<1481::AID-IMMU1481>3.0.CO;2-4
   RUFF VA, 1995, J BIOL CHEM, V270, P22602, DOI 10.1074/jbc.270.38.22602
   Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x
   Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775
   Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942
   Teixeira LK, 2005, J IMMUNOL, V175, P5931, DOI 10.4049/jimmunol.175.9.5931
   Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001
   van Rietschoten JGI, 2001, J BIOL CHEM, V276, P34509, DOI 10.1074/jbc.M102536200
   Vukcevic M, 2010, J BIOL CHEM, V285, P16003, DOI 10.1074/jbc.M109.066704
   Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x
   Wittmann M, 2006, J LEUKOCYTE BIOL, V80, P75, DOI 10.1189/jlb.0605328
   Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892
   Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200
   Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406
   Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1
   Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118
   Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200
   Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154
NR 35
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD SEP
PY 2014
VL 219
IS 9
BP 704
EP 712
DI 10.1016/j.imbio.2014.05.001
PG 9
WC Immunology
SC Immunology
GA AL9PC
UT WOS:000339472200007
PM 24894426
DA 2020-11-10
ER

PT J
AU Rodrigues-da-Silva, RN
   Lima, JD
   Fonseca, BDFE
   Antas, PRZ
   Baldez, A
   Storer, FL
   Santos, F
   Banic, DM
   de Oliveira-Ferreira, J
AF Rodrigues-da-Silva, Rodrigo Nunes
   Lima-Junior, Josue da Costa
   Fonseca e Fonseca, Bruna de Paula
   Zuquim Antas, Paulo Renato
   Baldez, Arlete
   Storer, Fabio Luiz
   Santos, Fatima
   Banic, Dalma Maria
   de Oliveira-Ferreira, Joseli
TI Alterations in cytokines and haematological parameters during the acute
   and convalescent phases of Plasmodium falciparum and Plasmodium vivax
   infections
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE cytokines; chemokines; platelets; P. falciparum; P. vivax
ID NECROSIS-FACTOR-ALPHA; IN-VITRO; CLINICAL IMMUNITY; T-CELLS; MALARIA;
   ANEMIA; THROMBOCYTOPENIA; PLATELET; CHILDREN; BLOOD
AB Haematological and cytokine alterations in malaria are a broad and controversial subject in the literature. However, few studies have simultaneously evaluated various cytokines in a single patient group during the acute and convalescent phases of infection. The aim of this study was to sequentially characterise alterations in haematological patters and circulating plasma cytokine and chemokine levels in patients infected with Plasmodium vivax or Plasmodium falciparum from a Brazilian endemic area during the acute and convalescent phases of infection. During the acute phase, thrombocytopaenia, eosinopaenia, lymphopaenia and an increased number of band cells were observed in the majority of the patients. During the convalescent phase, the haematologic parameters returned to normal. During the acute phase, P. vivax and P. falciparum patients had significantly higher interleukin (IL)-6, IL-8, IL-17, interferon-gamma, tumour necrosis factor (TNF)-alpha, macrophage inflammatory protein-1 beta and granulocyte-colony stimulating factor levels than controls and maintained high levels during the convalescent phase. IL-10 was detected at high concentrations during the acute phase, but returned to normal levels during the convalescent phase. Plasma IL-10 concentration was positively correlated with parasitaemia in P. vivax and P. falciparum-infected patients. The same was true for the TNF-alpha concentration in P. falciparum-infected patients. Finally, the haematological and cytokine profiles were similar between uncomplicated P. falciparum and P. vivax infections.
C1 [Rodrigues-da-Silva, Rodrigo Nunes; Lima-Junior, Josue da Costa; de Oliveira-Ferreira, Joseli] Inst Oswaldo Cruz, Lab Imunoparasitol, Rio De Janeiro, RJ, Brazil.
   [Zuquim Antas, Paulo Renato] Inst Oswaldo Cruz, Lab Imunol Clin, Rio De Janeiro, RJ, Brazil.
   [Banic, Dalma Maria] Inst Oswaldo Cruz, Lab Simulideos & Oncocercose, Rio De Janeiro, RJ, Brazil.
   [Fonseca e Fonseca, Bruna de Paula] Biomanguinhos Fiocruz, Lab Tecnol Diagnost, Rio De Janeiro, RJ, Brazil.
   [Baldez, Arlete] Secretaria Estado Saude Sao Paulo, Agencia Vigilancia Saude, Porto Velho, RO, Brazil.
   [Storer, Fabio Luiz] Fac Sao Lucas, Porto Velho, RO, Brazil.
   [Santos, Fatima] Odebrecht Energia Usina Hidreletr Santo Antonio, Porto Velho, RO, Brazil.
RP de Oliveira-Ferreira, J (corresponding author), Inst Oswaldo Cruz, Lab Imunoparasitol, Rio De Janeiro, RJ, Brazil.
EM lila@ioc.fiocruz.br
RI Lima-Junior, Josue/B-1361-2014; ANTAS, PRZ/AAF-6021-2019;
   Oliveira-Ferreira, Joseli/E-7942-2014
OI Lima-Junior, Josue/0000-0002-5848-404X; Oliveira-Ferreira,
   Joseli/0000-0002-6063-465X; Rodrigues-da-Silva, Rodrigo
   Nunes/0000-0002-9772-849X; Fonseca, Bruna de Paula/0000-0002-8795-2578
FU DECIT; CNPqNational Council for Scientific and Technological Development
   (CNPq)
FX DECIT, CNPq
CR AGARWAL SS, 1983, INDIAN J MED RES, V77, P616
   Akanmori BD, 2000, EUR CYTOKINE NETW, V11, P113
   Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13
   Araujo CF, 2008, MEM I OSWALDO CRUZ, V103, P517, DOI 10.1590/S0074-02762008000600001
   Armah Henry, 2005, Int J Environ Res Public Health, V2, P123, DOI 10.3390/ijerph2005010123
   Aubouy A, 2002, ACTA TROP, V83, P195, DOI 10.1016/S0001-706X(02)00094-3
   Balde AT, 2000, PARASITE IMMUNOL, V22, P307, DOI 10.1046/j.1365-3024.2000.00307.x
   Baptista JL, 1997, TROP MED INT HEALTH, V2, P673, DOI 10.1046/j.1365-3156.1997.d01-355.x
   Brown H, 1999, J INFECT DIS, V180, P1742, DOI 10.1086/315078
   Bueno LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021289
   Casals-Pascual C, 2006, AM J TROP MED HYG, V75, P434, DOI 10.4269/ajtmh.2006.75.434
   Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836
   Collins WE, 2003, AM J TROP MED HYG, V68, P410, DOI 10.4269/ajtmh.2003.68.410
   Corrigan RA, 2010, PARASITE IMMUNOL, V32, P512, DOI 10.1111/j.1365-3024.2010.01225.x
   Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771
   Cox-Singh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020541
   DAVIS TME, 1991, ACTA TROP, V48, P243, DOI 10.1016/0001-706X(91)90052-L
   Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016
   Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408
   Eisenhut M, 2010, PARASITE IMMUNOL, V32, P470, DOI 10.1111/j.1365-3024.2010.01214.x
   El-Nashar Thanaa M., 2002, Journal of the Egyptian Society of Parasitology, V32, P525
   Ghosh K, 2007, PARASITOL RES, V101, P1463, DOI 10.1007/s00436-007-0742-1
   Gonzalez B, 2009, INVEST CLIN, V50, P187
   Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007
   Hanscheid T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-109
   Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771
   Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x
   Hviid L, 1997, INFECT IMMUN, V65, P4090, DOI 10.1128/IAI.65.10.4090-4093.1997
   Karunaweera ND, 2003, TRENDS PARASITOL, V19, P188, DOI 10.1016/S1471-4922(03)00036-9
   KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6
   KUMARATILAKE LM, 1992, J IMMUNOL, V149, P194
   Kurtzhals JAL, 1998, CLIN EXP IMMUNOL, V112, P303
   KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5
   Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205
   Lathia T B, 2004, Indian J Med Sci, V58, P239
   Leowattana W, 2010, SE ASIAN J TROP MED, V41, P1035
   Lima JD, 2012, MEM I OSWALDO CRUZ, V107, P1035, DOI 10.1590/S0074-02762012000800012
   Medina TS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-264
   Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97
   Mendonca VRR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-69
   Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a
   Fernandes AAM, 2008, CLIN VACCINE IMMUNOL, V15, P650, DOI 10.1128/CVI.00475-07
   MS - Ministerio da Saude Brasil, 2010, GUIA PRAT TRAT MAL B
   Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
   Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548
   Patel U, 2004, J NATL MED ASSOC, V96, P1212
   PEYRON F, 1994, CLIN EXP IMMUNOL, V95, P300, DOI 10.1111/j.1365-2249.1994.tb06527.x
   Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614
   Ramharter M, 2003, PARASITE IMMUNOL, V25, P211, DOI 10.1046/j.1365-3024.2003.00628.x
   Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221
   Sina Barbara, 2002, Trends in Parasitology, V18, P287, DOI 10.1016/S1471-4922(02)02329-2
   Tangpukdee N, 2008, PARASITOL INT, V57, P490, DOI 10.1016/j.parint.2008.06.005
   Taylor WRJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-259
   Ventura A M, 1999, J Pediatr (Rio J), V75, P187
   Wassmer SC, 2008, J INFECT DIS, V197, P72, DOI 10.1086/523761
   Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35
   Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072
   Wilson NO, 2010, INFECT DIS OBSTET GY, V2010
NR 60
TC 27
Z9 27
U1 0
U2 8
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD APR
PY 2014
VL 109
IS 2
BP 154
EP 162
DI 10.1590/0074-0276140275
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AJ7VQ
UT WOS:000337908500004
PM 24676654
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU Sanchez-Arcila, JC
   Perce-da-Silva, DD
   Vasconcelos, MPA
   Rodrigues-da-Silva, RN
   Pereira, VA
   Aprigio, CL
   Lima, CAM
   Fonseca, BDFE
   Banic, DM
   Lima, JD
   Oliveira-Ferreira, J
AF Sanchez-Arcila, Juan Camilo
   Perce-da-Silva, Daiana de Souza
   Alves Vasconcelos, Mariana Pinheiro
   Rodrigues-da-Silva, Rodrigo Nunes
   Pereira, Virginia Araujo
   Lima Aprigio, Cesarino Junior
   Mendes Lima, Cleoni Alves
   Fonseca e Fonseca, Bruna de Paula
   Banic, Dalma Maria
   Lima-Junior, Josue da Costa
   Oliveira-Ferreira, Joseli
TI Intestinal Parasites Coinfection Does Not Alter Plasma Cytokines Profile
   Elicited in Acute Malaria in Subjects from Endemic Area of Brazil
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; SCHISTOSOMA-HAEMATOBIUM INFECTION;
   HELMINTH INFECTIONS; IMMUNE-RESPONSES; NITRIC-OXIDE;
   ASCARIS-LUMBRICOIDES; INFLAMMATORY MARKERS; CONVALESCENT PHASES;
   RURAL-COMMUNITY; RONDONIA-STATE
AB In Brazil, malaria is prevalent in the Amazon region and these regions coincide with high prevalence of intestinal parasites but few studies explore the interaction between malaria and other parasites. Therefore, the present study evaluates changes in cytokine, chemokine, C-reactive protein, and nitric oxide (NO) concentrations in 264 individuals, comparing plasma from infected individuals with concurrent malaria and intestinal parasites to individuals with either malaria infection alone and uninfected. In the studied population 24% of the individuals were infected with Plasmodium and 18% coinfected with intestinal parasites. Protozoan parasites comprised the bulk of the intestinal parasites infections and subjects infected with intestinal parasites were more likely to have malaria. The use of principal component analysis and cluster analysis associated increased levels of IL-6, TNF-alpha, IL-10, and CRP and lowlevels of IL-17A predominantly with individuals with malaria alone and coinfected individuals. In contrast, lowlevels of almost all inflammatory mediators were associated predominantly with individuals uninfected while increased levels of IL-17A were associated predominantly with individuals with intestinal parasites only. In conclusion, our data suggest that, in our population, the infection with intestinal parasites (mainly protozoan) does not modify the pattern of cytokine production in individuals infected with P. falciparum and P. vivax.
C1 [Sanchez-Arcila, Juan Camilo; Rodrigues-da-Silva, Rodrigo Nunes; Pereira, Virginia Araujo; Lima-Junior, Josue da Costa; Oliveira-Ferreira, Joseli] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Imunoparasitol, BR-21040900 Rio De Janeiro, Brazil.
   [Perce-da-Silva, Daiana de Souza; Banic, Dalma Maria] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Simulideos & Oncocercose, BR-21040900 Rio De Janeiro, Brazil.
   [Alves Vasconcelos, Mariana Pinheiro] Inst Infectol Emilio Ribas, BR-01246900 Sao Paulo, Brazil.
   [Lima Aprigio, Cesarino Junior] Agencia Vigilancia Saude Secretaria Estado Saude, BR-78900000 Porto Velho, RO, Brazil.
   [Mendes Lima, Cleoni Alves] Univ Fed Rondonia, Ctr Interdepartamental Biol Expt & Biotecnol, BR-78900000 Porto Velho, RO, Brazil.
   [Fonseca e Fonseca, Bruna de Paula] Fundacao Oswaldo Cruz, Lab Tecnol Diagnost, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Oliveira-Ferreira, J (corresponding author), Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Imunoparasitol, BR-21040900 Rio De Janeiro, Brazil.
EM lila@ioc.fiocruz.br
RI Vasconcelos, Mariana Pinheiro Alves/M-8832-2019; Lima-Junior,
   Josue/B-1361-2014; Oliveira-Ferreira, Joseli/E-7942-2014
OI Vasconcelos, Mariana Pinheiro Alves/0000-0001-7211-6887; Lima-Junior,
   Josue/0000-0002-5848-404X; Fonseca, Bruna de Paula/0000-0002-8795-2578;
   Rodrigues-da-Silva, Rodrigo Nunes/0000-0002-9772-849X;
   Oliveira-Ferreira, Joseli/0000-0002-6063-465X
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ,
   Brazil)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Pronex Malaria; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)National Council
   for Scientific and Technological Development (CNPq); Instituto Oswaldo
   Cruz (FIOCRUZ, Brazil); Pronex Malaria/CNPq/DECIT/MS; CNPqNational
   Council for Scientific and Technological Development (CNPq); Instituto
   Oswaldo Cruz
FX The authors are in debt to the individuals who participated in this
   study and Andrea Sanchez Tapia for revising the paper. This work was
   supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ, Brazil), Pronex Malaria, Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, Brazil), Instituto Oswaldo Cruz
   (FIOCRUZ, Brazil), Pronex Malaria/CNPq/DECIT/MS. JOF is recipient of a
   Research Productivity Fellowship from CNPq, and JCSA is recipient of a
   fellowship from Instituto Oswaldo Cruz and VAR from CNPq.
CR [Anonymous], 2010, WHEELER B LMPERM PER
   Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557
   Araujo CF, 2005, REV SOC BRAS MED TRO, V38, P69, DOI 10.1590/S0037-86822005000100016
   Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x
   Bejon P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000164
   Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702
   Cabantous S, 2009, J INFECT DIS, V200, P1530, DOI 10.1086/644600
   CARDOSO MA, 1992, REV SAUDE PUBL, V26, P161, DOI 10.1590/S0034-89101992000300006
   CARDOSO MA, 1994, EUR J CLIN NUTR, V48, P326
   Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800
   Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016
   de Souza EA, 2007, CAD SAUDE PUBLICA, V23, P427, DOI 10.1590/S0102-311X2007000200019
   Diallo TO, 2004, PARASITE IMMUNOL, V26, P365, DOI 10.1111/j.0141-9838.2004.00719.x
   Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408
   Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08
   Eve E, 1998, ANN TROP MED PARASIT, V92, P79, DOI 10.1080/00034989860201
   FERRARI JO, 1992, REV I MED TROP, V34, P223, DOI 10.1590/S0036-46651992000300007
   Figueiredo CA, 2010, INFECT IMMUN, V78, P3160, DOI 10.1128/IAI.01228-09
   Fleming FM, 2006, TROP MED INT HEALTH, V11, P56, DOI 10.1111/j.1365-3156.2005.01541.x
   Geiger SM, 2002, PARASITE IMMUNOL, V24, P499, DOI 10.1046/j.1365-3024.2002.00600.x
   Goncalves RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044394
   Goncalves RM, 2010, INFECT IMMUN, V78, P4763, DOI 10.1128/IAI.00578-10
   Helmby H, 1998, INFECT IMMUN, V66, P5167, DOI 10.1128/IAI.66.11.5167-5174.1998
   Imai N, 2011, PARASITOLOGY, V138, P1519, DOI 10.1017/S0031182011001181
   KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6
   Klion AD, 2004, J ALLERGY CLIN IMMUN, V113, P30, DOI 10.1016/j.jaci.2003.10.050
   Lima JD, 2012, MEM I OSWALDO CRUZ, V107, P1035, DOI 10.1590/S0074-02762012000800012
   Ludbrook J, 1998, AM STAT, V52, P127, DOI 10.2307/2685470
   Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124
   Lyke KE, 2006, INFECT IMMUN, V74, P5718, DOI 10.1128/IAI.01822-05
   Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x
   Meeusen ENT, 2000, PARASITOL TODAY, V16, P95, DOI 10.1016/S0169-4758(99)01607-5
   Melo GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011206
   MURRAY MJ, 1977, AM J CLIN NUTR, V30, P2117
   Nacher M, 2000, PARASITE IMMUNOL, V22, P107, DOI 10.1046/j.1365-3024.2000.00284.x
   Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834
   Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2
   Nahrevanian H, 2001, PARASITE IMMUNOL, V23, P491, DOI 10.1046/j.1365-3024.2001.00406.x
   Noone C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-5
   Oksanen J., 2010, VEGAN COMMUNITY ECOL
   Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720
   Pullan R, 2008, PARASITOLOGY, V135, P783, DOI 10.1017/S0031182008000346
   R Core Team, 2013, LANG ENV STAT COMP
   Remoue F, 2003, T ROY SOC TROP MED H, V97, P361, DOI 10.1016/S0035-9203(03)90170-2
   Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x
   Rockett K. A., 1994, AM J TROP MED HYG, V50, P112
   Rodrigues-da-Silva RN, 2014, MEM I OSWALDO CRUZ, V109, P154, DOI 10.1590/0074-0276140275
   Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007359
   Rubino SJ, 2012, TRENDS IMMUNOL, V33, P112, DOI 10.1016/j.it.2012.01.003
   Shapiro AE, 2005, T ROY SOC TROP MED H, V99, P18, DOI 10.1016/j.trstmh.2004.02.006
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43
   Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9
   Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005
   Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003
   Tangpukdee N, 2008, PARASITOL INT, V57, P490, DOI 10.1016/j.parint.2008.06.005
   Taylor WRJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-259
   Tshikuka JG, 1996, ANN TROP MED PARASIT, V90, P277, DOI 10.1080/00034983.1996.11813053
   Turner JD, 2003, J INFECT DIS, V188, P1768, DOI 10.1086/379370
   Turner JD, 2008, J INFECT DIS, V197, P1204, DOI 10.1086/586717
   Valverde JG, 2011, ANN TROP MED PARASIT, V105, P413, DOI 10.1179/1364859411Y.0000000034
   Warnes G. R., 2014, VARIOUS R PROGRAMMIN
NR 62
TC 6
Z9 6
U1 0
U2 8
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PY 2014
VL 2014
AR 857245
DI 10.1155/2014/857245
PG 12
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA AS4OX
UT WOS:000344256800001
PM 25309052
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU Fonseca, BPF
   Marques, CFS
   Nascimento, LD
   Mello, MB
   Silva, LBR
   Rubim, NM
   Foti, L
   Silva, ED
   Ferreira, AGP
   Krieger, MA
AF Fonseca, Bruna P. F.
   Marques, Christiane F. S.
   Nascimento, Lilian D.
   Mello, Marcelle B.
   Silva, Leila B. R.
   Rubim, Nara M.
   Foti, Leonardo
   Silva, Edimilson D.
   Ferreira, Antonio G. P.
   Krieger, Marco A.
TI Development of a Multiplex Bead-Based Assay for Detection of Hepatitis C
   Virus
SO CLINICAL AND VACCINE IMMUNOLOGY
LA English
DT Article
ID ANTIBODIES; IMMUNOASSAYS; RESPONSES; 2ND-GENERATION; INFECTION;
   DIAGNOSIS; PROTEINS; ANTIGENS; DISEASE; BLOOD
AB Hepatitis C virus (HCV) infection is a major burden to public health worldwide, affecting approximately 3% of the human population. Although HCV detection is currently based on reliable tests, the field of medical diagnostics has a growing need for inexpensive, accurate, and quick high-throughput assays. By using the recombinant HCV antigens NS3, NS4, NS5, and Combined, we describe a new bead-based multiplex test capable of detecting HCV infection in human serum samples. The first analysis, made in a singleplex format, showed that each antigen coupled to an individual bead set presented high-level responses for anti-HCV-positive reference serum pools and lower-level responses for the HCV-negative pools. Our next approach was to determine the sensitivity and specificity of each antigen by testing 93 HCV-positive and 93 HCV-negative sera. When assayed in the singleplex format, the NS3, NS4, and NS5 antigens presented lower sensitivity values (50.5%, 51.6%, and 55.9%, respectively) than did the Combined antigen, which presented a sensitivity of 93.5%. All antigens presented 100% specificity. These antigens were then multiplexed in a 4-plex assay, which resulted in increased sensitivity and specificity values, performing with 100% sensitivity and 100% specificity. The positive and negative predictive values for the 4-plex assay were 100%. Although preliminary, this 4-plex assay showed robust results that, aligned with its small-sample-volume requirements and also its cost-and time-effectiveness, make it a reasonable alternative to tests currently used for HCV screening of potentially infected individuals.
C1 [Fonseca, Bruna P. F.; Marques, Christiane F. S.; Nascimento, Lilian D.; Mello, Marcelle B.; Silva, Leila B. R.; Rubim, Nara M.; Silva, Edimilson D.; Ferreira, Antonio G. P.] Bio Manguinhos Fiocruz, Lab Tecnol Diagnost, BR-21045900 Rio De Janeiro, Brazil.
   [Foti, Leonardo; Krieger, Marco A.] Inst Carlos Chagas Fiocruz, BR-81350010 Curitiba, Parana, Brazil.
   [Foti, Leonardo; Krieger, Marco A.] Inst Biol Mol Parana, BR-81350010 Curitiba, Parana, Brazil.
RP Fonseca, BPF (corresponding author), Bio Manguinhos Fiocruz, Lab Tecnol Diagnost, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM bruna.fonseca@bio.fiocruz.br
RI Krieger, Marco/AAE-8611-2020; Publica, Inct Saude/J-9544-2013; P,
   CM/B-1358-2013; Foti, Leonardo/F-1763-2014
OI Foti, Leonardo/0000-0003-2948-9914; Fonseca, Bruna de
   Paula/0000-0002-8795-2578
CR Abdel-Hamid M, 2002, J CLIN MICROBIOL, V40, P1656, DOI 10.1128/JCM.40.5.1656-1659.2002
   ALTER HJ, 1992, HEPATOLOGY, V15, P350, DOI 10.1002/hep.1840150228
   Ansari M. H. K., 2006, Hepatitis Monthly, V6, P19
   ARAUJO ES, 2007, BRAZ J INFECT DIS, V11, P446
   Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332
   BAATH L, 1992, J VIROL METHODS, V40, P287, DOI 10.1016/0166-0934(92)90087-T
   Beld M, 1999, HEPATOLOGY, V29, P1288, DOI 10.1002/hep.510290442
   Bellisario R, 2001, EARLY HUM DEV, V64, P21, DOI 10.1016/S0378-3782(01)00167-0
   Binnicker MJ, 2008, CLIN VACCINE IMMUNOL, V15, P1410, DOI 10.1128/CVI.00082-08
   Boyer N, 2000, J HEPATOL, V32, P98, DOI 10.1016/S0168-8278(00)80419-5
   Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1
   de Voer RM, 2008, CLIN VACCINE IMMUNOL, V15, P1188, DOI 10.1128/CVI.00478-07
   Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023
   Foti L, 2009, MEM I OSWALDO CRUZ, V104, P136, DOI 10.1590/S0074-02762009000900019
   Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06
   Fulton RJ, 1997, CLIN CHEM, V43, P1749
   GOURI L, 2004, CLIN DIAGN LAB IMMUN, V11, P272
   Jani IV, 2002, LANCET INFECT DIS, V2, P243, DOI 10.1016/S1473-3099(02)00242-6
   Joos TO, 2002, CURR OPIN CHEM BIOL, V6, P76, DOI 10.1016/S1367-5931(01)00289-7
   Kellar KL, 2002, EXP HEMATOL, V30, P1227, DOI 10.1016/S0301-472X(02)00922-0
   Pawlotsky JM, 2002, HEPATOLOGY, V36, pS65, DOI 10.1053/jhep.2002.36815
   Raedler MD, 2009, CLIN VACCINE IMMUNOL, V16, P739, DOI 10.1128/CVI.00478-08
   Sillanpaa M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-84
   Thimme R, 2008, BIOL CHEM, V389, P457, DOI 10.1515/BC.2008.061
NR 24
TC 11
Z9 12
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1556-6811
EI 1556-679X
J9 CLIN VACCINE IMMUNOL
JI Clin. Vaccine Immunol.
PD MAY
PY 2011
VL 18
IS 5
BP 802
EP 806
DI 10.1128/CVI.00265-10
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 758IB
UT WOS:000290156600016
PM 21346054
OA Green Published, Bronze
DA 2020-11-10
ER

PT J
AU Olsen, PC
   Ferreira, TPT
   Serra, MF
   Farias, FA
   Fonseca, BP
   Viola, JPB
   Cordeiro, RSB
   Silva, PMR
   Costa, JCS
   Martins, MA
AF Olsen, P. C.
   Ferreira, T. P. T.
   Serra, M. F.
   Farias-Filho, F. A.
   Fonseca, B. P.
   Viola, J. P. B.
   Cordeiro, R. S. B.
   Silva, P. M. R.
   Costa, J. C. S.
   Martins, M. A.
TI Lidocaine-derivative JMF2-1 prevents ovalbumin-induced airway
   inflammation by regulating the function and survival of T cells
SO CLINICAL AND EXPERIMENTAL ALLERGY
LA English
DT Article
DE apoptosis; asthma; lidocaine; lung inflammation; T cells
ID NEBULIZED LIDOCAINE; INDUCED APOPTOSIS; ASTHMA; LUNG; HYPERREACTIVITY;
   MICE; DEXAMETHASONE; EOSINOPHILS; ACTIVATION; THYMOCYTES
AB Background Inhalation of the local anaesthetic lidocaine has been suggested to be beneficial for asthmatics, but airway anaesthesia is unpleasant and may exacerbate bronchoconstriction. Our previous study showed that inhalation of the lidocaine analogue JMF2-1 can elicit the anti-inflammatory properties of lidocaine without anaesthesia. This prompted further research on the mechanism of action and putative therapeutic application of JMF2-1.
   Objective We tested the hypothesis that JMF2-1 would prevent allergen-induced lung inflammation and airway hyperresponsiveness (AHR) by modulating T cell function in vivo and in vitro.
   Methods Local and systemic changes in leucocyte levels, cytokine production and lung mechanics were examined in a murine model of lung inflammation. JMF2-1 (0.05-2%) or saline was aerosolized twice a day during the ovalbumin (OVA)-provocation period (19-21 days post-sensitization). Analyses were performed 24 h after the final challenge. Primary cultured lymph node cells were used to assess the effects of JMF2-1 (100-600 mu M) at the cellular level.
   Results OVA challenge resulted in lung recruitment of CD4(+) T cells and eosinophils, increased generation of inflammatory cytokines and AHR to inhaled methacholine within 24 h. These changes were prevented by JMF2-1 nebulization, and occurred in parallel with an increase in the number of apoptotic cells in the lung. JMF2-1 treatment did not alter levels of CD4(+) or CD8(+) T cells in the thymus or lymph nodes of naive mice, although it inhibited OVA-induced IL-13 production and the lymphocyte proliferative response in vitro. It also induced apoptosis of OVA-activated lymphocytes in a mechanism sensitive to z-VAD, indicating that JMF2-1 mediates caspase-dependent apoptosis.
   Conclusion Inhalation of JMF2-1 prevents the cardinal features of asthma by reducing T(H)2 cytokine generation and lung eosinophilic inflammatory infiltrates via local inhibition of T cell function and survival. JMF2-1 may represent a novel therapeutic alternative for asthma control with distinct advantages over local anaesthetics.
C1 [Olsen, P. C.; Ferreira, T. P. T.; Serra, M. F.; Farias-Filho, F. A.; Cordeiro, R. S. B.; Silva, P. M. R.; Martins, M. A.] Oswaldo Cruz Fdn FIOCRUZ, Lab Inflammat, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Fonseca, B. P.; Viola, J. P. B.] INCA, Div Cellular Biol, Rio De Janeiro, Brazil.
RP Martins, MA (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Lab Inflammat, Inst Oswaldo Cruz, Av Brazil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM mmartins@ioc.fiocruz.br
RI Publica, Inct Saude/J-9544-2013; SILVA, PATRICIA MACHADO RODRIGUES
   E/AAS-4906-2020; Olsen, Priscilla C/I-8994-2012; Viola,
   Joao/AAP-4125-2020
OI Olsen, Priscilla C/0000-0002-8795-037X; Viola, Joao/0000-0002-0698-3146;
   Fonseca, Bruna de Paula/0000-0002-8795-2578
FU CAPESCAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [573.564/2008-6]; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Programa de Desenvolvimento Tecnologico em Insumos para Saude
   (PDTIS), FIOCRUZ, Brazil
FX We are indebted to Tatiane Perez Oliveira dos Santos for technical
   support. Priscilla C. Olsen acknowledges CAPES for her Fellowship. These
   investigations were supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), INCT-INOFAR (Projeto
   CNPq no. 573.564/2008-6), Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Programa de
   Desenvolvimento Tecnologico em Insumos para Saude (PDTIS), FIOCRUZ,
   Brazil.
CR Adcock IM, 2008, CURR ALLERGY ASTHM R, V8, P171, DOI 10.1007/s11882-008-0028-4
   Barnes PJ, 2004, NAT REV DRUG DISCOV, V3, P831, DOI 10.1038/nrd1524
   BEYDON L, 1995, INTENS CARE MED, V21, P920, DOI 10.1007/BF01712333
   Burches BR, 2008, ANESTH ANALG, V107, P1260, DOI 10.1213/ane.0b013e31817d8637
   Costa JCS, 2008, BIOORG MED CHEM LETT, V18, P1162, DOI 10.1016/j.bmcl.2007.11.122
   FERGUSON RM, 1976, J IMMUNOL, V116, P627
   Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195
   Harrison TW, 1998, RESP MED, V92, P1359, DOI 10.1016/S0954-6111(98)90142-1
   Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y
   Hirota K, 1999, BRIT J ANAESTH, V82, P87
   Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x
   Holgate ST, 2006, J ALLERGY CLIN IMMUN, V117, P496, DOI 10.1016/j.jaci.2006.01.039
   Hunt LW, 1996, MAYO CLIN PROC, V71, P361, DOI 10.4065/71.4.361
   Hunt LW, 2004, J ALLERGY CLIN IMMUN, V113, P853, DOI 10.1016/j.jaci.2004.02.039
   Ivanov VN, 1998, INT IMMUNOL, V10, P1807, DOI 10.1093/intimm/10.12.1807
   Kips JC, 2001, EUR RESPIR J, V18, p24S, DOI 10.1183/09031936.01.00229601
   Kodama T, 1998, CLIN EXP ALLERGY, V28, P1435
   Lahat A, 2008, CLIN EXP IMMUNOL, V152, P320, DOI 10.1111/j.1365-2249.2008.03636.x
   Li XM, 1996, J IMMUNOL, V157, P3216
   McColl KS, 1998, MOL CELL ENDOCRINOL, V139, P229, DOI 10.1016/S0303-7207(98)00051-3
   MIGLIORATI G, 1993, BLOOD, V81, P1352
   Moore WC, 2008, AM J RESP CRIT CARE, V177, P1068, DOI 10.1164/rccm.200802-315UP
   Muraki M, 2008, INT IMMUNOPHARMACOL, V8, P725, DOI 10.1016/j.intimp.2008.01.021
   Okada S, 1998, J IMMUNOL, V160, P4010
   Proust B, 2003, CLIN EXP ALLERGY, V33, P119, DOI 10.1046/j.1365-2222.2003.01560.x
   Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238
   Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08
   Saito Keiko, 2006, Nihon Kokyuki Gakkai Zasshi, V44, P828
   da Costa JCS, 2007, J ALLERGY CLIN IMMUN, V119, P219, DOI 10.1016/j.jaci.2006.08.037
   STAM WB, 1993, LIFE SCI, V53, P1921, DOI 10.1016/0024-3205(93)90014-T
   Tanaka A, 2002, J ALLERGY CLIN IMMUN, V109, P485, DOI 10.1067/mai.2002.122155
   Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x
   Woolley KL, 1996, AM J RESP CRIT CARE, V154, P237, DOI 10.1164/ajrccm.154.1.8680686
NR 33
TC 26
Z9 27
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-7894
EI 1365-2222
J9 CLIN EXP ALLERGY
JI Clin. Exp. Allergy
PD FEB
PY 2011
VL 41
IS 2
BP 250
EP 259
DI 10.1111/j.1365-2222.2010.03580.x
PG 10
WC Allergy; Immunology
SC Allergy; Immunology
GA 706JE
UT WOS:000286213600014
PM 20874831
DA 2020-11-10
ER

PT J
AU Foti, L
   Fonseca, BDFE
   Nascimento, LD
   Marques, CDS
   da Silva, ED
   Duarte, CAB
   Probst, CM
   Goldenberg, S
   Pinto, AG
   Krieger, MA
AF Foti, Leonardo
   Fonseca e Fonseca, Bruna de Paula
   Nascimento, Lilian Dias
   Silva Marques, Christiane de Fatima
   da Silva, Edmilson Domingos
   Barros Duarte, Cesar Augusto
   Probst, Christian M.
   Goldenberg, Samuel
   Pinto, Antonio Gomes
   Krieger, Marco Aurelio
TI Viability study of a multiplex diagnostic platform for Chagas disease
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Proceedings Paper
CT International Symposium on the Centennial of the Discovery of Chargas
   Disease
CY JUL 08-10, 2009
CL Rio de Janeiro, BRAZIL
DE Chagas disease; diagnostic; multiplex; bead-based assay; Trypanosoma
   cruzi
ID TRYPANOSOMA-CRUZI; INFECTIOUS-DISEASES; ASSAY; IMMUNOASSAYS; ANTIBODIES;
   ANTIGENS
AB A new multiplex assay platform was evaluated to detect Trypanosoma cruzi infection using the recombinant antigens CRA, FRA, CRAFRA fusion and parasite lysate. The antigens presented different sensitivity and specificity in a singleplex test when compared to a serial dilution of two pools comprising 10 positive serum samples and one pool of 10 negative samples. The recombinant protein CRA presented lower sensitivity (55%) in contrast to the 100% specificity and sensitivity of FRA, CRAFRA and T. cruzi lysate. These antigens also showed good results in a duplex test and the duplex test with CRAFRA/T. cruzi lysate showed better performance with 100% specificity and sensitivity, as well as a lower cut-off value in comparison to the other duplex test, FRA/T. cruzi lysate. Hence, when the antigens were used in duplex format, both tests showed decreased cut-off values and no interference between different bead sets, resulting in increasing sensitivity and specificity. The results of these multiplex tests show that they could be an alternative to singleplex detection for Chagas disease, and also indicate the necessity of using multiplex diagnostic tools to increase the sensitivity and specificity for diagnostic tests. Emerging data from the T. cruzi genome and from its ORFeome project will also allow the identification of new antigens for this disease detection application.
C1 [Foti, Leonardo; Barros Duarte, Cesar Augusto; Probst, Christian M.; Goldenberg, Samuel; Krieger, Marco Aurelio] Fiocruz MS, Inst Carlos Chagas, BR-81350010 Curitiba, Parana, Brazil.
   [Fonseca e Fonseca, Bruna de Paula; Nascimento, Lilian Dias; Silva Marques, Christiane de Fatima; da Silva, Edmilson Domingos; Pinto, Antonio Gomes] Fiocruz MS, Lab Tecnol Diagnost, BR-21045900 Rio De Janeiro, Brazil.
RP Krieger, MA (corresponding author), Fiocruz MS, Inst Carlos Chagas, R Prof Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.
EM mkrieger@fiocruz.br
RI Krieger, Marco/AAE-8611-2020; P, CM/B-1358-2013; Probst,
   Christian/B-8678-2009; Foti, Leonardo/F-1763-2014; GOLDENBERG,
   SAMUEL/B-4116-2009
OI Probst, Christian/0000-0001-9993-6375; Foti,
   Leonardo/0000-0003-2948-9914; GOLDENBERG, SAMUEL/0000-0002-4892-163X;
   Fonseca, Bruna de Paula/0000-0002-8795-2578
CR Bern C, 2008, REV SOC BRAS MED TRO, V41, P315
   BRENER Z, 2000, TRYPANOSSOMA CRUZI D
   Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1
   Chen Yunjia, 2008, V426, P209, DOI 10.1007/978-1-60327-058-8_13
   Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316
   Coura JR, 2007, MEM I OSWALDO CRUZ, V102, P113, DOI 10.1590/S0074-02762007000900018
   Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005
   El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631
   Hay Burgess Deborah C, 2006, Nature, V444 Suppl 1, P1
   Hopkins AL, 2007, NATURE, V449, P166, DOI 10.1038/449166a
   Jani IV, 2002, LANCET INFECT DIS, V2, P243, DOI 10.1016/S1473-3099(02)00242-6
   Joos TO, 2002, CURR OPIN CHEM BIOL, V6, P76, DOI 10.1016/S1367-5931(01)00289-7
   King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134
   KRIEGER MA, 1992, AM J TROP MED HYG, V46, P427, DOI 10.4269/ajtmh.1992.46.427
   Lal G, 2004, CLIN DIAGN LAB IMMUN, V11, P272, DOI 10.1128/CDLI.11.2.272-279.2004
   Lee SH, 2004, THEOR APPL GENET, V110, P167, DOI 10.1007/s00122-004-1827-1
   Leon JS, 2001, INFECT IMMUN, V69, P5643, DOI 10.1128/IAI.69.9.5643-5649.2001
   LopezAntunano FJ, 1997, SALUD PUBLICA MEXICO, V39, P463, DOI 10.1590/S0036-36341997000500009
   Luan CH, 2004, GENOME RES, V14, P2102, DOI 10.1101/gr.2520504
   Martins TB, 2004, CLIN DIAGN LAB IMMUN, V11, P1054, DOI 10.1128/CDLI.11.6.1054-1059.2004
   O'Connell D, 2007, NATURE, V449, P157, DOI 10.1038/449157a
   O'Meara WP, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-36
   Prabhakar U, 2002, J IMMUNOL METHODS, V260, P207, DOI 10.1016/S0022-1759(01)00543-9
   Rual JF, 2004, CURR OPIN CHEM BIOL, V8, P20, DOI 10.1016/j.cbpa.2003.12.002
   Schmunis GA, 2005, CLIN MICROBIOL REV, V18, P12, DOI 10.1128/CMR.18.1.12-29.2005
   *TDR, 2007, REP GRUP TRAB CIENT
   Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448
   Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6
   Villa L, 2007, MEM I OSWALDO CRUZ, V102, P87, DOI 10.1590/S0074-02762007005000081
   Yan XM, 2005, ANAL CHEM, V77, P7673, DOI 10.1021/ac0508797
NR 30
TC 13
Z9 14
U1 0
U2 4
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUL
PY 2009
VL 104
SU 1
BP 136
EP 141
DI 10.1590/S0074-02762009000900019
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 485LM
UT WOS:000269123500018
PM 19753468
OA DOAJ Gold
DA 2020-11-10
ER

PT J
AU Fonseca, BPF
   Olsen, PC
   Coelh, LP
   Ferreira, TPT
   Souza, HS
   Martins, MA
   Viola, JPB
AF Fonseca, Bruna P. F.
   Olsen, Priscilla C.
   Coelh, Luciana P.
   Ferreira, Tatiana P. T.
   Souza, Heitor S.
   Martins, Marco A.
   Viola, Joo P. B.
TI NFAT1 Transcription Factor Regulates Pulmonary Allergic Inflammation and
   Airway Responsiveness
SO AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
LA English
DT Article
DE allergic inflammation; asthma; NFAT; immune response; lung
ID CHRONIC SEVERE ASTHMA; ACTIVATED T-CELLS; BRONCHIAL HYPERRESPONSIVENESS;
   CYCLOSPORINE-A; SMOOTH-MUSCLE; MURINE MODEL; DEFICIENT MICE;
   ACETYLCHOLINE; EOSINOPHILS; RECEPTORS
AB Allergic asthma is a chronic inflammatory disease of the lung whose incidence and morbidity continues to rise in developed nations. Despite being a hallmark of asthma, the molecular mechanisms that determine airway hyperresponsiveness (AHR) are not completely established. Transcription factors of the NFAT family are involved in the regulation of several asthma-related genes. It has been shown that the absence of NFAT1 leads to an increased pleural eosinophilic allergic response accompanied by an increased production of Th2 cytokines, suggesting a role for NFAT1 in the regulation of allergic diseases. Herein, we analyze NFAT1-/- mice to address the role of NFAT1 in a model of allergic airway inflammation and its influence in AHR. NFAT1-/- mice submitted to airway inflammation display a significant exacerbation of several features of the allergic disease, including lung inflammation, eosinophilia, and serum IgE levels, which were concomitant with elevated Th2 cytokine production. However, in spite of the increased allergic phenotype, NFAT1-/- mice failed to express AHR after methacholine aerosol. Refractoriness of NFAT1-/- mice to methacholine was confirmed in naive mice, suggesting that this refractoriness occurs in an intrinsic way, indepenclent of the lung inflammation. In addition, NFAT1-/- mice exhibit increased AHR in response to serotonin inhalation, suggesting a specific role for NFAT1 in the methacholine pathway of bronchoconstriction. Taken together, these data add support to the interpretation that NFAT1 acts as a counterregulatory mechanism to suppress allergic inflammation. Moreover, our findings suggest a novel role for NFAT1 protein in airway responsiveness mediated by the cholinergic pathway.
C1 [Fonseca, Bruna P. F.; Viola, Joo P. B.] Natl Canc Inst, INCA, Div Cellular Biol, BR-20231050 Rio De Janeiro, Brazil.
   [Olsen, Priscilla C.; Coelh, Luciana P.; Ferreira, Tatiana P. T.; Martins, Marco A.] Fundacao Oswaldo Cruz, Dept Physiol & Pharmacodynam, Lab Inflammat, Rio De Janeiro, Brazil.
   [Souza, Heitor S.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Multidisciplinary Lab, Rio De Janeiro, Brazil.
RP Viola, JPB (corresponding author), Natl Canc Inst, INCA, Div Cellular Biol, Rua Andre Cavalcanti 37, BR-20231050 Rio De Janeiro, Brazil.
EM jpviola@inca.gov.br
RI Viola, Joao/AAP-4125-2020; de Souza, Heitor Siffert Pereira/G-3297-2012;
   Olsen, Priscilla C/I-8994-2012; Publica, Inct Saude/J-9544-2013
OI Viola, Joao/0000-0002-0698-3146; de Souza, Heitor Siffert
   Pereira/0000-0002-3647-7324; Olsen, Priscilla C/0000-0002-8795-037X;
   Fonseca, Bruna de Paula/0000-0002-8795-2578
CR ALEXANDER AG, 1992, LANCET, V339, P324, DOI 10.1016/0140-6736(92)91646-P
   Boss V, 1996, J BIOL CHEM, V271, P10429, DOI 10.1074/jbc.271.18.10429
   BRADLEY BL, 1991, J ALLERGY CLIN IMMUN, V88, P661, DOI 10.1016/0091-6749(91)90160-P
   Bymaster FP, 2003, NEUROCHEM RES, V28, P437, DOI 10.1023/A:1022844517200
   Chetta A, 1997, CHEST, V111, P852, DOI 10.1378/chest.111.4.852
   Chiba Y, 2004, INFLAMM RES, V53, P636, DOI 10.1007/s00011-004-1305-x
   Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716
   DESAI DM, 1990, NATURE, V348, P66, DOI 10.1038/348066a0
   Diehl S, 2004, J IMMUNOL, V172, P3597, DOI 10.4049/jimmunol.172.6.3597
   EIIAS JA, 2003, J CLIN INVEST, V111, P291
   Eum SY, 1999, BRIT J PHARMACOL, V126, P312, DOI 10.1038/sj.bjp.0702304
   FELDER CC, 1995, FASEB J, V9, P619
   Forsythe SM, 2002, AM J RESP CELL MOL, V26, P298, DOI 10.1165/ajrcmb.26.3.4564
   FUKUDA T, 1995, ANN ALLERG ASTHMA IM, V75, P65
   Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73
   Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031
   Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8
   Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8
   JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745
   Khan LN, 2000, AM J RESP CRIT CARE, V162, P1377, DOI 10.1164/ajrccm.162.4.9911117
   Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3
   Kummer W, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-65
   Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703
   Lee YC, 2006, INT IMMUNOPHARMACOL, V6, P703, DOI 10.1016/j.intimp.2005.10.007
   Lewis SA, 2001, EUR RESPIR J, V18, P921, DOI 10.1183/09031936.01.00211801
   Lloyd CM, 2001, J IMMUNOL, V166, P2033, DOI 10.4049/jimmunol.166.3.2033
   Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214
   Matsukawa A, 2000, EXP MOL PATHOL, V68, P77, DOI 10.1006/exmp.1999.2296
   MISAWA M, 1993, JPN J PHARMACOL, V61, P41, DOI 10.1254/jjp.61.41
   Moffatt JD, 2004, BRIT J PHARMACOL, V141, P1159, DOI 10.1038/sj.bjp.0705720
   Perez JF, 2005, J GEN PHYSIOL, V125, P535, DOI 10.1085/jgp.200409216
   Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3
   Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3
   Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707
   Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577
   Rogers DF, 2004, CURR OPIN PHARMACOL, V4, P241, DOI 10.1016/j.coph.2004.01.011
   Rogers DF, 2001, RESP PHYSIOL, V125, P129, DOI 10.1016/S0034-5687(00)00209-7
   Seminario MC, 2001, J ALLERGY CLIN IMMUN, V107, P143, DOI 10.1067/mai.2001.111931
   Stephens NL, 2003, RESP PHYSIOL NEUROBI, V137, P125, DOI 10.1016/S1569-9048(03)00142-3
   STRETTON D, 1992, J PHARMACOL EXP THER, V260, P1073
   Struckmann N, 2003, MOL PHARMACOL, V64, P1444, DOI 10.1124/mol.64.6.1444
   Ulrik CS, 2005, J ASTHMA, V42, P549, DOI 10.1080/02770900500215715
   Viola JPB, 1998, BLOOD, V91, P2223, DOI 10.1182/blood.V91.7.2223.2223_2223_2230
   WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I
   WHICKER S D, 1990, Pulmonary Pharmacology, V3, P129, DOI 10.1016/0952-0600(90)90043-I
   Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255
   Woodruff PG, 2001, J ALLERGY CLIN IMMUN, V108, P753, DOI 10.1067/mai.2001.119411
   WU J, 1995, MOL CELL BIOL, V15, P4337
   Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892
   Yurdakul AS, 2005, J ASTHMA, V42, P843, DOI 10.1080/02770900500370981
NR 50
TC 14
Z9 14
U1 1
U2 2
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1044-1549
EI 1535-4989
J9 AM J RESP CELL MOL
JI Am. J. Respir. Cell Mol. Biol.
PD JAN
PY 2009
VL 40
IS 1
BP 66
EP 75
DI 10.1165/rcmb.2007-0102OC
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
SC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
GA 388XW
UT WOS:000262054700009
PM 18664642
DA 2020-11-10
ER

PT J
AU Magalhaes, ES
   Mourao-Sa, DS
   Vieira-de-Abreu, A
   Figueiredo, RT
   Pires, AL
   Farias, FA
   Fonseca, BPF
   Viola, JPB
   Metz, C
   Martins, MA
   Castro-Faria-Neto, HC
   Bozza, PT
   Bozza, MT
AF Magalhaes, Elizabeth S.
   Mourao-Sa, Diego S.
   Vieira-de-Abreu, Adriana
   Figueiredo, Rodrigo T.
   Pires, Ana L.
   Farias-Filho, Francisco A.
   Fonseca, Bruna P. F.
   Viola, Joao P. B.
   Metz, Christine
   Martins, Marco A.
   Castro-Faria-Neto, Hugo C.
   Bozza, Patricia T.
   Bozza, Marcelo T.
TI Macrophage migration inhibitory factor is essential for allergic asthma
   but not for Th2 differentiation
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE airway hyper-responsiveness; asthma; eosinophils; inflammation; Th1-Th2
ID INDUCED AIRWAY INFLAMMATION; FACTOR MIF; REGULATORY ROLE; MURINE MODEL;
   DEFICIENT; MOUSE; LEUKOTRIENES; EOSINOPHILS; CYTOKINE; MICE
AB Macrophage migration inhibitory factor (MIF) is increased in asthmatic patients and plays a critical role in the pathogenesis of asthma. We show here that mice lacking MIF failed to develop airway hyper-responsiveness (AHR), tissue eosinophilia, and mucus metaplasia. Analysis of the bronchoalveolar fluids revealed a substantial reduction of IL-13, eotaxin and cysteinyl-leukotrienes. The lack of these cardinal features of asthma in MIF-/- mice occurs regardless of high concentrations of IL-4 in the lung and OVA-specific IgE in the serum. Antigen-specific lymphocyte proliferation and IL-13 production were similarly increased in the draining lymph nodes of OVA-immunized and challenged MIF-/- mice compared to WT, but were reduced in the spleen of MIF-/-, thus indicating differential roles of MIF in these compartments. Stimulation of naive CD4(+) cells with anti-CD3 antibody demonstrated that MIF-/- cells produced increased amounts of IFN-gamma and IL-4 compared to WT CD4(+) cells. Finally, treatment of sensitized BALB/c mice with neutralizing anti-MIF antibody abrogated the development of ARH and airway inflammation without affecting the production of Th2 cytokines or IgE. The present study demonstrates that MIF is required for allergic inflammation, adding important elements to our knowledge of asthma pathogenesis and suggesting that neutralization of MIF might be of therapeutic value in asthma.
C1 Univ Fed Rio de Janeiro, Dept Immunol, Inst Microbiol, BR-21941902 Rio De Janeiro, Brazil.
   IOC Fiocruz, Dept Fisiol & Farmacodinam, Rio De Janeiro, Brazil.
   Inst Nacl Canc, Div Biol Celular, Rio De Janeiro, Brazil.
   Inst Med Res N Shore LIJ, Lab Med Biochem, Manhasset, NY USA.
RP Bozza, MT (corresponding author), Univ Fed Rio de Janeiro, Dept Immunol, Inst Microbiol, CCS Bloco 1,Ave Carlos Chagas Filho,373 Cidade Un, BR-21941902 Rio De Janeiro, Brazil.
EM mbozza@micro.ufrj.br
RI Viola, Joao/AAP-4125-2020; Mourao-Sa, Diego/C-5977-2009; Figueiredo,
   Rodrigo T./F-5176-2016
OI Viola, Joao/0000-0002-0698-3146; Figueiredo, Rodrigo
   T./0000-0002-7551-8782; Christine, Metz/0000-0002-1013-1691; Mourao,
   Diego/0000-0001-6618-6969; Fonseca, Bruna de Paula/0000-0002-8795-2578;
   Bozza, Marcelo/0000-0003-3683-7550; Bozza, Patricia/0000-0001-8349-9529
CR Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849
   Bacher M, 1997, AM J PATHOL, V150, P235
   Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004
   Baumann R, 2003, FASEB J, V17, P2221, DOI 10.1096/fj.03-0110com
   BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0
   BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025
   Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8
   Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341
   Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200
   Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262
   CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0
   Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109
   de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720
   Denkinger CM, 2003, J IMMUNOL, V170, P1274, DOI 10.4049/jimmunol.170.3.1274
   Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320
   Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748
   Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195
   Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157
   Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261
   Hamelmann E, 1997, AM J RESP CRIT CARE, V155, P819, DOI 10.1164/ajrccm.155.3.9117011
   Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051
   Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483
   Hua ZX, 1998, HUM PATHOL, V29, P1441, DOI 10.1016/S0046-8177(98)90013-2
   Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283
   Kobayashi M, 2006, EUR RESPIR J, V27, P726, DOI 10.1183/09031936.06.00107004
   Korsgren M, 2000, MEDIAT INFLAMM, V9, P15, DOI 10.1080/09629350050024339
   Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455
   Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472
   Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B
   Lehmann LE, 2001, INTENS CARE MED, V27, P1412, DOI 10.1007/s001340101022
   Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286
   Lloyd CM, 2001, J IMMUNOL, V166, P2033, DOI 10.4049/jimmunol.166.3.2033
   Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100
   Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102
   NAGAI H, 1993, LIFE SCI, V53, pPL243
   Nakamaru Y, 2005, CYTOKINE, V31, P103, DOI 10.1016/j.cyto.2005.04.002
   Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2
   Qiang Y, 2003, J IMMUNOL, V170, P1473, DOI 10.4049/jimmunol.170.3.1473
   Rodriguez-Sosa M, 2003, INFECT IMMUN, V71, P1247, DOI 10.1128/IAI.71.3.1247-1254.2003
   Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a
   Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524
   Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001
   Stavitsky AB, 2003, PARASITE IMMUNOL, V25, P369, DOI 10.1046/j.1365-3024.2003.00641.x
   Topilski I, 2002, J IMMUNOL, V168, P1610, DOI 10.4049/jimmunol.168.4.1610
   Vargaftig BB, 2003, AM J RESP CELL MOL, V28, P410, DOI 10.1165/rcmb.2002-0032OC
   Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V284, pL260, DOI 10.1152/ajplung.00226.2002
   Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668
   Wang B, 2006, J IMMUNOL, V177, P5779, DOI 10.4049/jimmunol.177.9.5779
   Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255
   Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258
   Yamaguchi E, 2000, CLIN EXP ALLERGY, V30, P1244
   Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909
NR 52
TC 25
Z9 26
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD APR
PY 2007
VL 37
IS 4
BP 1097
EP 1106
DI 10.1002/eji.200635968
PG 10
WC Immunology
SC Immunology
GA 159HX
UT WOS:000245857300023
PM 17373669
OA Bronze
DA 2020-11-10
ER

PT J
AU Teixeira, LK
   Fonseca, BPF
   Vieira-de-Abreu, A
   Barboza, BA
   Robbs, BK
   Bozza, PT
   Viola, JPB
AF Teixeira, LK
   Fonseca, BPF
   Vieira-de-Abreu, A
   Barboza, BA
   Robbs, BK
   Bozza, PT
   Viola, JPB
TI IFN-gamma production by CD8(+) T cells depends on NFAT1 transcription
   factor and regulates Th differentiation
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID INDUCED AIRWAY HYPERRESPONSIVENESS; REDUCED INTERFERON-GAMMA; NUCLEAR
   FACTOR; MICE LACKING; EOSINOPHIL RECRUITMENT; DENDRITIC CELLS; IL-4
   EXPRESSION; IN-VIVO; INFLAMMATION; BET
AB CD8(+) T lymphocytes are excellent sources of IFN-gamma; however, the molecular mechanisms that dictate IFN-gamma expression upon TCR stimulation in these cells are not completely understood. In this study, we evaluated the involvement of NFAT1 in the regulation of IFN-gamma gene expression in murine CD8(+) T cells and its relevance during Th differentiation. We show that CD8(+), but not CD4(+), T cells, represent the very first source of IFN-gamma upon primary T cell activation, and also that the IFN-gamma produced by naive CD8(+) T cells may enhance CD4(+) Th1 differentiation in vitro. TCR stimulation rapidly induced IFN-gamma expression in CD8(+) T lymphocytes in a cyclosporin A-sensitive manner. Evaluation of CD8(+) T cells showed that calcium influx alone was sufficient to activate NFAT1 protein, transactivate IFN-gamma gene promoter, and induce IFN-gamma production. In fact, NFAT1-deficient mice demonstrated highly impaired IFN-gamma production by naive CD8(+) T lymphocytes, which were totally rescued,after retroviral transduction with NFAT1-encoding vectors. Moreover, NFAT1-dependent IFN-gamma production by the CD8(+) T cell compartment was crucial to control a Th2-related response in vivo, such as allergic inflammation. Consistently, CD8 alpha- as well as IFN-gamma-deficient mice did not mount a Th1 immune response and also developed in vivo allergic inflammation. Our results clearly indicate that IFN-gamma production by CD8(+) T cells is dependent of NFAT1 transcription factor and maybe an essential regulator of Th immune responses in vivo.
C1 Inst Nacl Canc, Div Biol Celular, BR-20231050 Rio De Janeiro, Brazil.
   Oswaldo Cruz Fdn, Dept Physiol & Pharmacodynam, Lab Immunopharmacol, Rio De Janeiro, Brazil.
RP Viola, JPB (corresponding author), Inst Nacl Canc, Div Biol Celular, Rua Andre Cavalcanti 37, BR-20231050 Rio De Janeiro, Brazil.
EM jpviola@inca.gov.br
RI Teixeira, Leonardo Karam/S-8773-2016; Viola, Joao/AAP-4125-2020; Robbs,
   Bruno/H-5553-2013
OI Teixeira, Leonardo Karam/0000-0001-6117-423X; Viola,
   Joao/0000-0002-0698-3146; Bozza, Patricia/0000-0001-8349-9529; Fonseca,
   Bruna de Paula/0000-0002-8795-2578; Robbs, Bruno/0000-0002-3972-5530
CR ABBAS AK, 1996, NATURE, V383, P78
   Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794
   Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808
   Avots A, 1999, IMMUNITY, V10, P515, DOI 10.1016/S1074-7613(00)80051-5
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Bradley LM, 1996, J IMMUNOL, V157, P1350
   CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0
   Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309
   Coyle AJ, 1996, J IMMUNOL, V156, P2680
   Das G, 2001, J IMMUNOL, V167, P2004, DOI 10.4049/jimmunol.167.4.2004
   Diehl S, 2004, J IMMUNOL, V172, P3597, DOI 10.4049/jimmunol.172.6.3597
   Dow SW, 1999, HUM GENE THER, V10, P1905, DOI 10.1089/10430349950017266
   Elser B, 2002, IMMUNITY, V17, P703, DOI 10.1016/S1074-7613(02)00471-5
   Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544
   Fulkerson PC, 2004, P NATL ACAD SCI USA, V101, P1987, DOI 10.1073/pnas.0308544100
   Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031
   Hamelmann E, 1996, J EXP MED, V183, P1719, DOI 10.1084/jem.183.4.1719
   Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155
   Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8
   IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573
   JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0
   Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3
   Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480
   Leonard C, 1997, AM J RESP CELL MOL, V17, P368, DOI 10.1165/ajrcmb.17.3.2797
   Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497
   Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598
   LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H
   Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884
   Luttmann W, 2000, SCAND J IMMUNOL, V51, P54
   Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147
   Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587
   Maldonado-Lopez R, 2001, J IMMUNOL, V167, P4345, DOI 10.4049/jimmunol.167.8.4345
   Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138
   McMillin DW, 2005, BIOCHEM BIOPH RES CO, V330, P768, DOI 10.1016/j.bbrc.2005.03.035
   Miyahara N, 2004, J IMMUNOL, V172, P2549, DOI 10.4049/jimmunol.172.4.2549
   Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835
   Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451
   Nurse B, 1997, J ALLERGY CLIN IMMUN, V100, P662, DOI 10.1016/S0091-6749(97)70171-4
   Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148
   Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707
   Renzi PM, 1999, AM J RESP CRIT CARE, V159, P1417, DOI 10.1164/ajrccm.159.5.9805080
   SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223
   SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188
   SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205
   Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412
   Suzuki M, 2002, J ALLERGY CLIN IMMUN, V109, P803, DOI 10.1067/mai.2002.123233
   Suzuki M, 1999, J IMMUNOL, V163, P5574
   Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775
   Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543
   Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942
   Uzonna JE, 2004, J EXP MED, V199, P1559, DOI 10.1084/jem.20040172
   Viola JPB, 1998, BLOOD, V91, P2223, DOI 10.1182/blood.V91.7.2223.2223_2223_2230
   Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255
   Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892
   Zhang YK, 2001, J EXP MED, V194, P165, DOI 10.1084/jem.194.2.165
NR 55
TC 56
Z9 58
U1 0
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD NOV 1
PY 2005
VL 175
IS 9
BP 5931
EP 5939
DI 10.4049/jimmunol.175.9.5931
PG 9
WC Immunology
SC Immunology
GA 977EW
UT WOS:000232786300048
PM 16237086
OA Other Gold
DA 2020-11-10
ER

PT J
AU Viola, JPB
   Carvalho, LDS
   Fonseca, BPF
   Teixeira, LK
AF Viola, JPB
   Carvalho, LDS
   Fonseca, BPF
   Teixeira, LK
TI NFAT transcription factors: from cell cycle to tumor development
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 11th Brazilian Congress of Cellular Biology
CY JUL 15-18, 2004
CL Campinas, BRAZIL
DE NFAT; cell cycle; cancer; cell differentiation; gene expression
ID ACTIVATED T-CELLS; SWISS 3T3 FIBROBLASTS; NUCLEAR FACTOR; CYTOKINE
   GENES; CYCLOSPORINE-A; GROWTH-FACTOR; MICE LACKING; TH2 CELLS;
   EXPRESSION; CALCINEURIN
AB The nuclear factor of activated T cells (NFAT) family of transcription factors has been primarily identified in immune cells; however, these proteins have been recently found to be functionally active in several other non-immune cell types. NFAT proteins are activated upon different stimuli that lead to increased intracellular calcium levels. Regardless of their widely known cytokine gene expression properties, NFATs have been shown to regulate other genes related to cell cycle progression, cell differentiation and apoptosis, revealing a broader role for these proteins in normal cell physiology. Several reports have addressed the participation of NFATs in many aspects of malignant cell transformation and tumorigenic processes. In this review, we will discuss the involvement of the different NFAT family members in the regulation of cell cycling, differentiation and tumor formation, and also its implications on oncogenesis. Better understanding the mechanisms by which NFATs regulate cell cycle and tumor-related events should be relevant for the development of rational anti-cancer therapies.
C1 Inst Nacl Canc, INCA, Div Biol Celular, BR-20231050 Rio De Janeiro, Brazil.
RP Viola, JPB (corresponding author), Inst Nacl Canc, INCA, Div Biol Celular, Rua Andre Cavalcanti 37,5 Andar, BR-20231050 Rio De Janeiro, Brazil.
EM jpviola@inca.gov.br
RI Teixeira, Leonardo Karam/S-8773-2016; Viola, Joao/AAP-4125-2020
OI Teixeira, Leonardo Karam/0000-0001-6117-423X; Viola,
   Joao/0000-0002-0698-3146; Fonseca, Bruna de Paula/0000-0002-8795-2578
CR Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0
   ANRAKU Y, 1991, BIOCHIM BIOPHYS ACTA, V1093, P169, DOI 10.1016/0167-4889(91)90119-I
   Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808
   Baksh S, 2000, ONCOGENE, V19, P2820, DOI 10.1038/sj.onc.1203585
   Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3
   Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112
   Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6
   Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje
   Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1
   Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297
   Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2
   Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8
   Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0
   Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607
   HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898
   Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8
   Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073
   Horsley V, 2003, J CELL BIOL, V161, P111, DOI 10.1083/jcb.200208085
   Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200
   JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138
   Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816
   JIANG H, 1993, CARCINOGENESIS, V14, P67, DOI 10.1093/carcin/14.1.67
   Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2
   Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0
   Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3
   Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9
   Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001
   Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884
   Luo C, 1996, MOL CELL BIOL, V16, P3955
   Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386
   MASUDA ES, 1995, MOL CELL BIOL, V15, P2697
   MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597
   Mosieniak G, 1997, J NEUROCHEM, V68, P1142
   Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4
   Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8
   Musaro A, 1999, NATURE, V400, P581
   Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200
   NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0
   Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146
   Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3
   Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9
   Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3
   Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707
   Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9
   Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X
   Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439
   RINCON M, 1997, CURR BIOL, V7, P729
   Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698
   SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404
   SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3
   TERADA N, 1991, J IMMUNOL, V147, P698
   Tomono M, 1998, ARCH BIOCHEM BIOPHYS, V353, P374, DOI 10.1006/abbi.1998.0667
   Tomono M, 1996, BIOCHEM J, V317, P675, DOI 10.1042/bj3170675
   Viola JPB, 1998, BLOOD, V91, P2223, DOI 10.1182/blood.V91.7.2223.2223_2223_2230
   Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892
   Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1
   Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474
   Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8
NR 60
TC 60
Z9 65
U1 0
U2 3
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD MAR
PY 2005
VL 38
IS 3
BP 335
EP 344
DI 10.1590/S0100-879X2005000300003
PG 10
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 909UV
UT WOS:000227887100003
PM 15761612
OA DOAJ Gold
DA 2020-11-10
ER

PT J
AU Teixeira, LK
   Fonseca, BPF
   Barboza, BA
   Viola, JPB
AF Teixeira, LK
   Fonseca, BPF
   Barboza, BA
   Viola, JPB
TI The role of interferon-gamma on immune and allergic responses
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Proceedings Paper
CT International Symposium on Nitric Oxide, Cytokines and Inflammation
CY JUN 06-09, 2004
CL Rio de Janeiro, BRAZIL
SP Oswaldo Cruz Fdn, Univ Calgary, Univ Calif Los Angeles, Brazilian Soc Pharmacol & Expt Therapeut, Canadian Assoc Gastroenterol
DE interferon-gamma; lymphocytes; immune system; allergy; allergic
   inflammation
ID INDUCED AIRWAY HYPERRESPONSIVENESS; CD4(+) T-CELLS; IFN-GAMMA;
   TRANSCRIPTION FACTOR; EOSINOPHIL RECRUITMENT; CYTOKINE PRODUCTION;
   GENE-EXPRESSION; MICE LACKING; T(H)1 CELLS; MAST-CELLS
AB Allergic diseases have been closely related to Th2 immune responses, which are characterized by high levels of interleukin (IL) IL-4, IL-5, IL-9 and IL-13. These cytokines orchestrate the recruitment and activation of different effector cells, such as eosinophils and mast cells. These cells along with Th2 cytokines are key players on the development of chronic allergic inflammatory disorders, usually characterized by airway hyperresponsiveness, reversible airway obstruction, and airway inflammation. Accumulating evidences have shown that altering cytokine-producing profile of Th2 cells by inducing Th1 responses may be protective against Th2-related diseases such as asthma and allergy. Interferon-gamma (IFN-gamma), the principal Th1 effector cytokine, has shown to be crucial for the resolution of allergic-related immunopathologies. In fact, reduced production of this cytokine has been correlated with severe asthma. In this review, we will discuss the role of IFN-gamma during the generation of immune responses and its influence on allergic inflammation models, emphasizing its biologic properties during the different aspects of allergic responses.
C1 Inst Nacl Canc, Div Biol Celular, BR-20231050 Rio De Janeiro, Brazil.
RP Viola, JPB (corresponding author), Inst Nacl Canc, Div Biol Celular, Rua Andre Cavalcanti 37, BR-20231050 Rio De Janeiro, Brazil.
EM jpviola@inca.gov.br
RI Viola, Joao/AAP-4125-2020; Teixeira, Leonardo Karam/S-8773-2016
OI Viola, Joao/0000-0002-0698-3146; Teixeira, Leonardo
   Karam/0000-0001-6117-423X; Fonseca, Bruna de Paula/0000-0002-8795-2578
CR Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0
   Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794
   Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563
   Bocek P, 2004, J EXP MED, V199, P1619, DOI 10.1084/jem.20032014
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   BOGUNIEWICZ M, 1995, J ALLERGY CLIN IMMUN, V95, P133, DOI 10.1016/S0091-6749(95)70162-1
   Bradley LM, 1996, J IMMUNOL, V157, P1350
   Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309
   Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297
   Coyle AJ, 1996, J IMMUNOL, V156, P2680
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   Desmedt M, 1998, J IMMUNOL, V160, P5300
   Dow SW, 1999, HUM GENE THER, V10, P1905, DOI 10.1089/10430349950017266
   Eastmond NC, 1997, J IMMUNOL, V159, P1444
   Elser B, 2002, IMMUNITY, V17, P703, DOI 10.1016/S1074-7613(02)00471-5
   FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035
   Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544
   FRANDJI P, 1995, CELL IMMUNOL, V163, P37, DOI 10.1006/cimm.1995.1096
   Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1
   Fulkerson PC, 2004, P NATL ACAD SCI USA, V101, P1987, DOI 10.1073/pnas.0308544100
   GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245
   Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898
   GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8
   HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166
   Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155
   HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432
   HOGMAN M, 1993, AM REV RESPIR DIS, V148, P1474
   Huang H, 1998, J EXP MED, V187, P1305, DOI 10.1084/jem.187.8.1305
   IGARASHI K, 1994, J BIOL CHEM, V269, P14333
   IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573
   Kodama T, 2003, CLIN EXP IMMUNOL, V131, P199, DOI 10.1046/j.1365-2249.2003.02073.x
   Lametschwandtner G, 2004, J ALLERGY CLIN IMMUN, V113, P987, DOI 10.1016/j.jaci.2004.02.004
   Lamkhioued B, 2003, J IMMUNOL, V170, P537, DOI 10.4049/jimmunol.170.1.537
   Leonard C, 1997, AM J RESP CELL MOL, V17, P368, DOI 10.1165/ajrcmb.17.3.2797
   Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598
   Luttmann W, 2000, SCAND J IMMUNOL, V51, P54
   Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807
   Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835
   Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451
   NAKAYAMA T, 1999, RRD PHOTOCHEM PHOTOB, V3, P103
   Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200
   Nurse B, 1997, J ALLERGY CLIN IMMUN, V100, P662, DOI 10.1016/S0091-6749(97)70171-4
   Patel HJ, 1999, FASEB J, V13, P1810
   Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148
   PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088
   Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4
   Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666
   Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577
   Renzi PM, 1999, AM J RESP CRIT CARE, V159, P1417, DOI 10.1164/ajrccm.159.5.9805080
   Sehra S, 2003, J IMMUNOL, V171, P2080, DOI 10.4049/jimmunol.171.4.2080
   Shi ZOQ, 2002, J IMMUNOL, V168, P4764
   Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77
   Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412
   Smart JM, 2002, J ALLERGY CLIN IMMUN, V110, P450, DOI 10.1067/mai.2002.127283
   Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593
   Suzuki M, 2002, J ALLERGY CLIN IMMUN, V109, P803, DOI 10.1067/mai.2002.123233
   Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775
   Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3
   Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942
   Tang CB, 2001, J IMMUNOL, V166, P1471, DOI 10.4049/jimmunol.166.3.1471
   Tau G, 1999, ALLERGY, V54, P1233, DOI 10.1034/j.1398-9995.1999.00099.x
   Tesfaigzi Y, 2002, J IMMUNOL, V169, P5919, DOI 10.4049/jimmunol.169.10.5919
   Wenner CA, 1996, J IMMUNOL, V156, P1442
   Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255
   Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3
   Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8
NR 66
TC 74
Z9 76
U1 0
U2 3
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAR
PY 2005
VL 100
SU 1
BP 137
EP 144
DI 10.1590/S0074-02762005000900024
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 918RE
UT WOS:000228564500024
PM 15962113
OA DOAJ Gold
DA 2020-11-10
ER

EF